• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 10-Q filed by Cycurion Inc.

    6/5/25 9:58:14 PM ET
    $CYCU
    EDP Services
    Technology
    Get the next $CYCU alert in real time by email
    false Q1 --12-31 0001868419 http://fasb.org/us-gaap/2024#LeaseholdImprovementsMember 0001868419 2025-01-01 2025-03-31 0001868419 CYCU:CommonStockParValue0.0001PerShareMember 2025-01-01 2025-03-31 0001868419 CYCU:RedeemableWarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember 2025-01-01 2025-03-31 0001868419 2025-06-05 0001868419 2025-03-31 0001868419 2024-12-31 0001868419 us-gaap:NonrelatedPartyMember 2025-03-31 0001868419 us-gaap:NonrelatedPartyMember 2024-12-31 0001868419 us-gaap:RelatedPartyMember 2025-03-31 0001868419 us-gaap:RelatedPartyMember 2024-12-31 0001868419 CYCU:SeriesAConvertiblePreferredStockMember 2025-03-31 0001868419 CYCU:SeriesAConvertiblePreferredStockMember 2024-12-31 0001868419 CYCU:SeriesBConvertiblePreferredStockMember 2025-03-31 0001868419 CYCU:SeriesBConvertiblePreferredStockMember 2024-12-31 0001868419 CYCU:SeriesCConvertiblePreferredStockMember 2025-03-31 0001868419 CYCU:SeriesCConvertiblePreferredStockMember 2024-12-31 0001868419 CYCU:SeriesDConvertiblePreferredStockMember 2025-03-31 0001868419 CYCU:SeriesDConvertiblePreferredStockMember 2024-12-31 0001868419 CYCU:SeriesEConvertiblePreferredStockMember 2025-03-31 0001868419 CYCU:SeriesEConvertiblePreferredStockMember 2024-12-31 0001868419 CYCU:SeriesAOneConvertiblePreferredStockMember 2025-03-31 0001868419 CYCU:SeriesAOneConvertiblePreferredStockMember 2024-12-31 0001868419 CYCU:CommonClassSubjectToRedemptionMember 2025-03-31 0001868419 CYCU:CommonClassSubjectToRedemptionMember 2024-12-31 0001868419 2024-01-01 2024-03-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesAConvertiblePreferredStockMember 2024-12-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesBConvertiblePreferredStockMember 2024-12-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesCConvertiblePreferredStockMember 2024-12-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesDConvertiblePreferredStockMember 2024-12-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesEConvertiblePreferredStockMember 2024-12-31 0001868419 us-gaap:CommonStockMember 2024-12-31 0001868419 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001868419 us-gaap:RetainedEarningsMember 2024-12-31 0001868419 us-gaap:ParentMember 2024-12-31 0001868419 us-gaap:NoncontrollingInterestMember 2024-12-31 0001868419 CYCU:CommonClassSubjectToRedemptionMember 2023-12-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesAConvertiblePreferredStockMember 2023-12-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesBConvertiblePreferredStockMember 2023-12-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesCConvertiblePreferredStockMember 2023-12-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesDConvertiblePreferredStockMember 2023-12-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesEConvertiblePreferredStockMember 2023-12-31 0001868419 us-gaap:CommonStockMember 2023-12-31 0001868419 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001868419 us-gaap:RetainedEarningsMember 2023-12-31 0001868419 us-gaap:ParentMember 2023-12-31 0001868419 CYCU:CommonClassSubjectToRedemptionMember 2025-01-01 2025-03-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesAConvertiblePreferredStockMember 2025-01-01 2025-03-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesBConvertiblePreferredStockMember 2025-01-01 2025-03-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesCConvertiblePreferredStockMember 2025-01-01 2025-03-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesDConvertiblePreferredStockMember 2025-01-01 2025-03-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesEConvertiblePreferredStockMember 2025-01-01 2025-03-31 0001868419 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001868419 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001868419 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001868419 us-gaap:ParentMember 2025-01-01 2025-03-31 0001868419 us-gaap:NoncontrollingInterestMember 2025-01-01 2025-03-31 0001868419 CYCU:CommonClassSubjectToRedemptionMember 2024-01-01 2024-03-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesAConvertiblePreferredStockMember 2024-01-01 2024-03-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesBConvertiblePreferredStockMember 2024-01-01 2024-03-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesCConvertiblePreferredStockMember 2024-01-01 2024-03-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesDConvertiblePreferredStockMember 2024-01-01 2024-03-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesEConvertiblePreferredStockMember 2024-01-01 2024-03-31 0001868419 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001868419 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001868419 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001868419 us-gaap:ParentMember 2024-01-01 2024-03-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesAConvertiblePreferredStockMember 2025-03-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesBConvertiblePreferredStockMember 2025-03-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesCConvertiblePreferredStockMember 2025-03-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesDConvertiblePreferredStockMember 2025-03-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesEConvertiblePreferredStockMember 2025-03-31 0001868419 us-gaap:CommonStockMember 2025-03-31 0001868419 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001868419 us-gaap:RetainedEarningsMember 2025-03-31 0001868419 us-gaap:ParentMember 2025-03-31 0001868419 us-gaap:NoncontrollingInterestMember 2025-03-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesBConvertiblePreferredStockMember 2024-03-31 0001868419 CYCU:CommonClassSubjectToRedemptionMember 2024-03-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesAConvertiblePreferredStockMember 2024-03-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesCConvertiblePreferredStockMember 2024-03-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesDConvertiblePreferredStockMember 2024-03-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesEConvertiblePreferredStockMember 2024-03-31 0001868419 us-gaap:CommonStockMember 2024-03-31 0001868419 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001868419 us-gaap:RetainedEarningsMember 2024-03-31 0001868419 us-gaap:ParentMember 2024-03-31 0001868419 2023-12-31 0001868419 2024-03-31 0001868419 CYCU:WesternAcquisitionVenturesCorpMember 2025-02-14 2025-02-14 0001868419 CYCU:WesternAcquisitionVenturesCorpMember us-gaap:CommonStockMember 2025-02-14 2025-02-14 0001868419 us-gaap:SeriesAPreferredStockMember CYCU:WesternAcquisitionVenturesCorpMember 2025-02-14 2025-02-14 0001868419 us-gaap:SeriesBPreferredStockMember CYCU:WesternAcquisitionVenturesCorpMember 2025-02-14 2025-02-14 0001868419 us-gaap:SeriesCPreferredStockMember CYCU:WesternAcquisitionVenturesCorpMember 2025-02-14 2025-02-14 0001868419 us-gaap:SeriesDPreferredStockMember CYCU:WesternAcquisitionVenturesCorpMember 2025-02-14 2025-02-14 0001868419 CYCU:SeriesAWarrantsMember CYCU:WesternAcquisitionVenturesCorpMember 2025-02-14 2025-02-14 0001868419 CYCU:SeriesBWarrantsMember CYCU:WesternAcquisitionVenturesCorpMember 2025-02-14 2025-02-14 0001868419 CYCU:SeriesDWarrantsMember CYCU:WesternAcquisitionVenturesCorpMember 2025-02-14 2025-02-14 0001868419 CYCU:CommonStockWarrantMember CYCU:WesternAcquisitionVenturesCorpMember 2025-02-14 2025-02-14 0001868419 CYCU:SeriesDPrivatePlacementMember CYCU:WesternAcquisitionVenturesCorpMember 2025-02-14 2025-02-14 0001868419 CYCU:AllianceGlobalPartnersMember us-gaap:CommonStockMember 2025-02-14 2025-02-14 0001868419 CYCU:SewardAndKisselLLPMember us-gaap:CommonStockMember 2025-02-14 2025-02-14 0001868419 CYCU:BakerAndHostetlerLLPMember us-gaap:CommonStockMember 2025-02-14 2025-02-14 0001868419 srt:MaximumMember 2025-03-31 0001868419 us-gaap:OfficeEquipmentMember 2025-03-31 0001868419 us-gaap:FurnitureAndFixturesMember 2025-03-31 0001868419 CYCU:CapitalLeaseMember 2025-03-31 0001868419 us-gaap:SoftwareDevelopmentMember 2025-03-31 0001868419 CYCU:AdvisoryConsultingMember 2025-01-01 2025-03-31 0001868419 CYCU:AdvisoryConsultingMember 2024-01-01 2024-03-31 0001868419 CYCU:ManagedSecurityServicePracticeMember 2025-01-01 2025-03-31 0001868419 CYCU:ManagedSecurityServicePracticeMember 2024-01-01 2024-03-31 0001868419 CYCU:SoftwareAsAServiceMember 2025-01-01 2025-03-31 0001868419 CYCU:SoftwareAsAServiceMember 2024-01-01 2024-03-31 0001868419 CYCU:SLGInnovationIncMember 2020-12-31 0001868419 CYCU:SLGInnovationIncMember 2024-12-31 0001868419 CYCU:SLGInnovationIncMember 2023-04-29 0001868419 CYCU:SLGInnovationIncMember 2023-04-29 2023-04-29 0001868419 CYCU:SLGInnovationIncMember CYCU:ReleaseAgreementMember 2025-03-31 0001868419 CYCU:SLGInnovationIncMember 2025-01-01 2025-03-31 0001868419 CYCU:SLGInnovationIncMember 2025-03-31 0001868419 CYCU:SLGInnovationIncMember us-gaap:SeriesEPreferredStockMember 2025-03-31 0001868419 2025-06-03 0001868419 us-gaap:EquipmentMember 2025-03-31 0001868419 us-gaap:EquipmentMember 2024-12-31 0001868419 us-gaap:FurnitureAndFixturesMember 2024-12-31 0001868419 us-gaap:LeaseholdImprovementsMember 2025-03-31 0001868419 us-gaap:LeaseholdImprovementsMember 2024-12-31 0001868419 CYCU:CapitalLeaseMember 2024-12-31 0001868419 CYCU:SoftwareMember 2025-03-31 0001868419 CYCU:SoftwareMember 2024-12-31 0001868419 us-gaap:CostOfSalesMember 2025-01-01 2025-03-31 0001868419 us-gaap:CostOfSalesMember 2024-01-01 2024-03-31 0001868419 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2025-01-01 2025-03-31 0001868419 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2024-01-01 2024-03-31 0001868419 us-gaap:SoftwareDevelopmentMember 2025-01-01 2025-03-31 0001868419 us-gaap:SoftwareDevelopmentMember 2024-01-01 2024-03-31 0001868419 us-gaap:SoftwareDevelopmentMember 2024-12-31 0001868419 CYCU:ContractualRelationshipMember 2025-03-31 0001868419 CYCU:ContractualRelationshipMember 2024-12-31 0001868419 CYCU:ImplementationMember 2025-03-31 0001868419 CYCU:ImplementationMember 2024-12-31 0001868419 CYCU:SoftwareMember 2025-03-31 0001868419 CYCU:SoftwareMember 2024-12-31 0001868419 CYCU:AxxumTechnologiesLLCMember CYCU:ShareTransferAgreementMember 2017-11-22 0001868419 CYCU:AxxumTechnologiesLLCMember CYCU:ShareTransferAgreementMember CYCU:TwoMember 2017-11-22 0001868419 CYCU:AxxumTechnologiesLLCMember CYCU:ShareTransferAgreementMember 2017-11-22 2017-11-22 0001868419 CYCU:CloudburstSecurityLLCMember CYCU:MembershipInterestPurchaseAgreementMember 2019-04-03 0001868419 CYCU:CloudburstSecurityLLCMember CYCU:MembershipInterestPurchaseAgreementMember CYCU:OneEquityHolderMember 2019-04-03 0001868419 CYCU:CloudburstSecurityLLCMember CYCU:MembershipInterestPurchaseAgreementMember CYCU:TwoEquityHolderMember 2019-04-03 0001868419 CYCU:CloudburstSecurityLLCMember CYCU:MembershipInterestPurchaseAgreementMember CYCU:OneEquityHolderMember 2019-04-03 2019-04-03 0001868419 CYCU:CloudburstSecurityLLCMember CYCU:MembershipInterestPurchaseAgreementMember CYCU:TwoEquityHolderMember 2019-04-03 2019-04-03 0001868419 CYCU:CloudburstSecurityLLCMember CYCU:MembershipInterestPurchaseAgreementMember 2019-04-03 2019-04-03 0001868419 CYCU:CloudburstSecurityLLCMember CYCU:ShareTransferAgreementMember 2019-04-03 0001868419 CYCU:CloudburstSecurityLLCMember CYCU:ShareTransferAgreementMember 2019-04-03 2019-04-03 0001868419 CYCU:CloudburstSecurityLLCMember CYCU:MembershipInterestPurchaseAgreementMember 2022-04-20 0001868419 CYCU:CloudburstSecurityLLCMember CYCU:MembershipInterestPurchaseAgreementMember 2022-04-20 2022-04-20 0001868419 CYCU:CloudburstSecurityLLCMember 2020-01-01 2020-12-31 0001868419 CYCU:CloudburstSecurityLLCMember 2025-03-31 0001868419 CYCU:SLGInnovationIncMember srt:MaximumMember 2024-12-31 0001868419 CYCU:SLGInnovationIncMember us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001868419 CYCU:SLGInnovationIncMember us-gaap:SeriesEPreferredStockMember 2025-01-01 2025-03-31 0001868419 CYCU:AxxumTechnologiesLLCMember 2025-03-31 0001868419 CYCU:AxxumTechnologiesLLCMember 2024-12-31 0001868419 CYCU:CloudburstSecurityLLCMember 2024-12-31 0001868419 CYCU:BankLoanRevolvingCreditLineMember 2017-11-22 0001868419 CYCU:BankLoanRevolvingCreditLineMember 2017-11-22 2017-11-22 0001868419 CYCU:BankLoanRevolvingCreditLineMember 2019-04-18 0001868419 CYCU:BankLoanRevolvingCreditLineMember 2019-04-18 2019-04-18 0001868419 CYCU:BankLoanRevolvingCreditLineMember 2020-06-29 2020-06-29 0001868419 CYCU:BankLoanRevolvingCreditLineMember 2021-06-30 2021-06-30 0001868419 CYCU:BankLoanRevolvingCreditLineMember 2025-01-01 2025-03-31 0001868419 CYCU:BankLoanRevolvingCreditLineMember 2025-03-31 0001868419 CYCU:BankLoanRevolvingCreditLineMember CYCU:AxxumLoanMember 2025-01-01 2025-03-31 0001868419 CYCU:BankLoanRevolvingCreditLineMember CYCU:LoanAndSecurityAgreementMember 2019-04-18 2019-04-18 0001868419 CYCU:BankLoanRevolvingCreditLineMember CYCU:LoanAndSecurityAgreementMember 2020-06-29 2020-06-29 0001868419 CYCU:BankLoanRevolvingCreditLineMember CYCU:LoanAndSecurityAgreementMember 2020-06-29 2020-06-29 0001868419 CYCU:BankLoanRevolvingCreditLineMember CYCU:LoanAndSecurityAgreementMember 2020-06-27 2020-06-29 0001868419 CYCU:PledgeagreementMember 2025-01-01 2025-03-31 0001868419 CYCU:PledgeagreementMember 2024-01-01 2024-03-31 0001868419 CYCU:SLGInnovationIncMember 2025-03-31 0001868419 CYCU:SLGInnovationIncMember 2024-12-31 0001868419 CYCU:CycurionMember 2025-03-31 0001868419 CYCU:CycurionMember 2024-12-31 0001868419 2023-03-20 2023-03-20 0001868419 2023-03-20 0001868419 CYCU:PromissoryNoteMember 2020-07-16 2020-07-16 0001868419 CYCU:EIDLLoanMember 2020-07-16 0001868419 CYCU:EIDLLoanMember 2020-07-16 2020-07-16 0001868419 CYCU:EIDLLoanMember 2025-03-31 0001868419 CYCU:EIDLLoanMember 2024-12-31 0001868419 CYCU:EIDLLoanMember CYCU:SLGInnovationIncMember 2020-09-30 2020-09-30 0001868419 CYCU:EIDLLoanMember CYCU:SLGInnovationIncMember 2020-09-30 0001868419 2017-12-31 0001868419 srt:MinimumMember 2017-12-31 0001868419 srt:MaximumMember 2017-12-31 0001868419 CYCU:PromissoryNotesOneMember 2025-03-31 0001868419 CYCU:PromissoryNotesOneMember 2024-12-31 0001868419 CYCU:PromissoryNotesOneMember 2025-01-01 2025-03-31 0001868419 CYCU:PromissoryNotesTwoMember 2025-03-31 0001868419 CYCU:PromissoryNotesTwoMember 2024-12-31 0001868419 CYCU:PromissoryNotesTwoMember srt:MinimumMember 2025-01-01 2025-03-31 0001868419 CYCU:PromissoryNotesTwoMember srt:MaximumMember 2025-01-01 2025-03-31 0001868419 CYCU:PromissoryNotesThreeMember 2025-03-31 0001868419 CYCU:PromissoryNotesThreeMember 2024-12-31 0001868419 CYCU:PromissoryNotesThreeMember srt:MinimumMember 2025-03-31 0001868419 CYCU:PromissoryNotesThreeMember srt:MaximumMember 2025-03-31 0001868419 CYCU:PromissoryNotesThreeMember 2025-01-01 2025-03-31 0001868419 CYCU:PromissoryNotesFourMember 2025-03-31 0001868419 CYCU:PromissoryNotesFourMember 2024-12-31 0001868419 CYCU:PromissoryNotesFourMember srt:MinimumMember 2025-03-31 0001868419 CYCU:PromissoryNotesFourMember srt:MaximumMember 2025-03-31 0001868419 CYCU:PromissoryNotesFourMember 2025-01-01 2025-03-31 0001868419 CYCU:PromissoryNotesFiveMember 2025-03-31 0001868419 CYCU:PromissoryNotesFiveMember 2024-12-31 0001868419 CYCU:PromissoryNotesFiveMember srt:MinimumMember 2025-03-31 0001868419 CYCU:PromissoryNotesFiveMember srt:MaximumMember 2025-03-31 0001868419 CYCU:PromissoryNotesFiveMember srt:MinimumMember 2025-01-01 2025-03-31 0001868419 CYCU:PromissoryNotesFiveMember srt:MaximumMember 2025-01-01 2025-03-31 0001868419 CYCU:PromissoryNotesMember 2025-03-31 0001868419 CYCU:PromissoryNotesMember 2024-12-31 0001868419 CYCU:UnaffiliatedInvestorMember 2025-03-31 0001868419 CYCU:UnaffiliatedInvestorMember 2025-01-01 2025-03-31 0001868419 CYCU:PromissoryNoteMember 2025-03-31 0001868419 CYCU:PromissoryNoteMember 2024-03-31 0001868419 CYCU:SixInvestorMember 2022-03-22 0001868419 2022-03-22 0001868419 CYCU:ThreeInvestorsMember 2022-03-22 0001868419 CYCU:FifthInvestorsMember 2022-03-22 0001868419 CYCU:SixthInvestorsMember 2022-03-22 0001868419 CYCU:UnaffiliatedInvestorMember 2022-11-22 0001868419 2022-11-22 2022-11-22 0001868419 2022-11-22 0001868419 CYCU:UnaffiliatedInvestorMember 2022-11-22 2022-11-22 0001868419 CYCU:BusinessCombinationAgreementMember 2022-11-21 0001868419 2023-11-21 0001868419 CYCU:BusinessCombinationAgreementMember 2025-01-01 2025-03-31 0001868419 CYCU:BusinessCombinationAgreementMember 2025-03-31 0001868419 CYCU:BusinessCombinationAgreementMember CYCU:SeriesDConvertiblePreferredStockMember 2025-01-01 2025-03-31 0001868419 CYCU:BusinessCombinationAgreementMember CYCU:SeriesDWarrantsMember CYCU:SevenUnaffiliatedInvestorMember 2025-01-01 2025-03-31 0001868419 CYCU:PromissoryNoteMember 2024-12-31 0001868419 CYCU:ConvertibleNotesPayableOneMember 2025-03-31 0001868419 CYCU:ConvertibleNotesPayableOneMember 2024-12-31 0001868419 CYCU:ConvertibleNotesPayableOneMember 2025-01-01 2025-03-31 0001868419 us-gaap:ConvertibleNotesPayableMember 2025-03-31 0001868419 us-gaap:ConvertibleNotesPayableMember 2024-12-31 0001868419 CYCU:ThreeUnaffiliatedInvestorMember 2025-03-31 0001868419 us-gaap:ConvertibleNotesPayableMember 2025-01-01 2025-03-31 0001868419 us-gaap:ConvertibleNotesPayableMember 2024-03-31 0001868419 2022-07-12 0001868419 CYCU:SeriesAConvertiblePreferredStockMember 2024-01-01 2024-12-31 0001868419 CYCU:SeriesAConvertiblePreferredStockMember srt:MinimumMember 2024-12-31 0001868419 CYCU:SeriesAConvertiblePreferredStockMember srt:MaximumMember 2024-12-31 0001868419 CYCU:SeriesAConvertiblePreferredStockMember us-gaap:PrivatePlacementMember CYCU:WesternAcquisitionVenturesCorpMember 2025-03-31 0001868419 CYCU:CommonClassSubjectToRedemptionMember 2025-03-31 0001868419 CYCU:CommonClassSubjectToRedemptionMember 2024-12-31 0001868419 CYCU:SeriesAConvertiblePreferredStockMember 2025-01-01 2025-03-31 0001868419 CYCU:SeriesAConvertiblePreferredStockMember 2025-01-01 2025-01-03 0001868419 CYCU:SeriesAConvertiblePreferredStockMember us-gaap:PrivatePlacementMember CYCU:WesternAcquisitionVenturesCorpMember 2024-12-31 0001868419 us-gaap:SeriesBPreferredStockMember 2025-01-01 2025-03-31 0001868419 CYCU:SeriesBConvertiblePreferredStockMember CYCU:WesternAcquisitionVenturesCorpMember 2025-03-31 0001868419 CYCU:SeriesBConvertiblePreferredStockMember CYCU:WesternAcquisitionVenturesCorpMember 2025-01-01 2025-03-31 0001868419 us-gaap:SeriesCPreferredStockMember 2025-03-31 0001868419 us-gaap:SeriesCPreferredStockMember 2025-01-01 2025-03-31 0001868419 CYCU:SeriesCConvertiblePreferredStockMember CYCU:WesternAcquisitionVenturesCorpMember 2025-01-01 2025-03-31 0001868419 us-gaap:SeriesDPreferredStockMember 2025-01-01 2025-03-31 0001868419 CYCU:SeriesDConvertiblePreferredStockMember CYCU:WesternAcquisitionVenturesCorpMember 2025-03-31 0001868419 CYCU:SeriesDConvertiblePreferredStockMember CYCU:WesternAcquisitionVenturesCorpMember 2025-01-01 2025-03-31 0001868419 us-gaap:SeriesEPreferredStockMember 2025-01-01 2025-03-31 0001868419 CYCU:SeriesEConvertiblePreferredStockMember CYCU:SLGInnovationMember 2025-03-31 0001868419 us-gaap:CommonStockMember CYCU:SeriesBandDConvertiblePreferredStockMember 2025-01-01 2025-03-31 0001868419 us-gaap:CommonStockMember CYCU:WarrantABandDMember 2025-01-01 2025-03-31 0001868419 us-gaap:CommonStockMember us-gaap:AcquisitionRelatedCostsMember 2025-01-01 2025-03-31 0001868419 us-gaap:CommonStockMember CYCU:SettlementOfDebtMember 2025-01-01 2025-03-31 0001868419 CYCU:SettlementOfDebtMember 2025-01-01 2025-03-31 0001868419 us-gaap:CommonStockMember CYCU:EmploymentAgreementMember 2025-01-01 2025-03-31 0001868419 us-gaap:CommonStockMember CYCU:SLGInnovationMember 2025-01-01 2025-03-31 0001868419 CYCU:CommonStockRedemptionMember 2025-01-01 2025-03-31 0001868419 CYCU:SLGInnovationMember 2025-03-31 0001868419 CYCU:PublicWarrantsMember 2025-03-31 0001868419 CYCU:PublicWarrantsMember 2024-12-31 0001868419 CYCU:PublicWarrantsMember 2025-01-01 2025-03-31 0001868419 CYCU:PrivatePlacementWarrantsMember 2025-03-31 0001868419 CYCU:PrivatePlacementWarrantsMember 2024-12-31 0001868419 CYCU:SeriesAWarrantsMember 2017-11-17 0001868419 CYCU:SeriesAWarrantsMember 2025-03-31 0001868419 CYCU:SeriesAWarrantsMember us-gaap:CommonStockMember 2025-03-31 0001868419 CYCU:SeriesBWarrantsMember 2023-08-01 0001868419 CYCU:SeriesBWarrantsMember 2024-04-12 0001868419 CYCU:SeriesBWarrantsMember 2025-03-31 0001868419 CYCU:SeriesBWarrantsMember us-gaap:CommonStockMember 2025-03-31 0001868419 CYCU:SeriesDWarrantsMember CYCU:SubordinatedConvertiblePromissoryNoteMember 2022-03-22 0001868419 CYCU:SeriesDWarrantsMember CYCU:SubordinatedConvertiblePromissoryNoteOneMember 2022-11-22 0001868419 CYCU:SeriesDWarrantsMember 2025-03-31 0001868419 CYCU:SeriesDWarrantsMember us-gaap:CommonStockMember 2025-03-31 0001868419 us-gaap:WarrantMember 2022-03-08 0001868419 us-gaap:WarrantMember 2022-03-08 2022-03-08 0001868419 CYCU:WarrantsMember 2025-03-31 0001868419 CYCU:WarrantsMember us-gaap:CommonStockMember 2025-03-31 0001868419 us-gaap:WarrantMember 2024-12-31 0001868419 us-gaap:WarrantMember 2024-01-01 2024-12-31 0001868419 us-gaap:WarrantMember 2025-01-01 2025-03-31 0001868419 us-gaap:WarrantMember 2025-03-31 0001868419 CYCU:ScandiumLLCMember 2025-01-01 2025-03-31 0001868419 CYCU:ScandiumLLCMember 2025-03-31 0001868419 CYCU:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-03-31 0001868419 CYCU:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0001868419 CYCU:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-03-31 0001868419 CYCU:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0001868419 CYCU:CustomerCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-03-31 0001868419 CYCU:CustomerCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0001868419 CYCU:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-03-31 0001868419 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember CYCU:CustomerOneMember 2025-01-01 2025-03-31 0001868419 CYCU:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-12-31 0001868419 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember CYCU:CustomerOneMember 2024-01-01 2024-12-31 0001868419 CYCU:CustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-03-31 0001868419 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember CYCU:CustomerTwoMember 2025-01-01 2025-03-31 0001868419 CYCU:CustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-12-31 0001868419 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember CYCU:CustomerTwoMember 2024-01-01 2024-12-31 0001868419 CYCU:CustomerThreeMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-03-31 0001868419 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember CYCU:CustomerThreeMember 2025-01-01 2025-03-31 0001868419 CYCU:CustomerThreeMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-12-31 0001868419 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember CYCU:CustomerThreeMember 2024-01-01 2024-12-31 0001868419 us-gaap:FairValueInputsLevel1Member 2025-03-31 0001868419 us-gaap:FairValueInputsLevel2Member 2025-03-31 0001868419 us-gaap:FairValueInputsLevel3Member 2025-03-31 0001868419 us-gaap:FairValueInputsLevel1Member 2024-12-31 0001868419 us-gaap:FairValueInputsLevel2Member 2024-12-31 0001868419 us-gaap:FairValueInputsLevel3Member 2024-12-31 0001868419 CYCU:SponsorMember 2024-09-20 0001868419 CYCU:SponsorMember 2024-09-20 2024-09-20 0001868419 CYCU:SponsorMember 2025-01-01 2025-03-31 0001868419 CYCU:PromissoryNoteMember 2025-01-01 2025-03-31 0001868419 CYCU:PromissoryNoteMember 2024-01-01 2024-03-31 0001868419 CYCU:TwoDirectorMember 2025-03-31 0001868419 CYCU:TwoDirectorMember 2024-12-31 0001868419 srt:DirectorMember 2025-03-31 0001868419 srt:DirectorMember 2024-12-31 0001868419 CYCU:SeriesAConvertiblePreferredStockMember 2024-01-01 2024-03-31 0001868419 CYCU:SeriesBConvertiblePreferredStockMember 2025-01-01 2025-03-31 0001868419 CYCU:SeriesBConvertiblePreferredStockMember 2024-01-01 2024-03-31 0001868419 CYCU:SeriesCConvertiblePreferredStockMember 2025-01-01 2025-03-31 0001868419 CYCU:SeriesCConvertiblePreferredStockMember 2024-01-01 2024-03-31 0001868419 CYCU:SeriesDConvertiblePreferredStockMember 2025-01-01 2025-03-31 0001868419 CYCU:SeriesDConvertiblePreferredStockMember 2024-01-01 2024-03-31 0001868419 CYCU:SeriesEConvertiblePreferredStockMember 2025-01-01 2025-03-31 0001868419 CYCU:SeriesEConvertiblePreferredStockMember 2024-01-01 2024-03-31 0001868419 CYCU:SewardAndKisselLLPMember 2024-11-27 2024-11-27 0001868419 CYCU:SewardAndKisselLLPMember 2024-11-27 0001868419 CYCU:BakerHostetlerLlpMember 2023-12-31 0001868419 CYCU:EquityPurchaseAgreementMember 2025-04-07 0001868419 CYCU:EquityPurchaseAgreementMember 2025-04-07 2025-04-07 0001868419 CYCU:PreFundedWarrantMember 2025-04-07 2025-04-07 0001868419 CYCU:PreFundedWarrantMember 2025-04-07 0001868419 CYCU:SponsorMember CYCU:NonRedemptionAgreementMember 2024-08-06 2024-08-06 0001868419 CYCU:SponsorMember CYCU:NonRedemptionAgreementMember 2024-10-08 2024-10-09 0001868419 2023-12-27 2023-12-27 0001868419 2023-12-27 0001868419 2024-10-30 2024-10-30 0001868419 2024-10-30 0001868419 srt:ChiefExecutiveOfficerMember CYCU:EmploymentAgreementMember 2024-12-01 2024-12-01 0001868419 srt:ChiefExecutiveOfficerMember CYCU:EmploymentAgreementMember 2025-01-01 2025-01-01 0001868419 us-gaap:CommonStockMember 2024-01-01 2024-12-31 0001868419 us-gaap:SubsequentEventMember 2025-04-07 2025-04-07 0001868419 us-gaap:SubsequentEventMember 2025-04-08 2025-04-08 0001868419 us-gaap:SubsequentEventMember 2025-04-09 0001868419 us-gaap:SubsequentEventMember srt:MinimumMember 2025-04-09 0001868419 us-gaap:SubsequentEventMember 2025-04-11 2025-04-11 0001868419 us-gaap:SubsequentEventMember 2025-04-11 0001868419 us-gaap:SubsequentEventMember 2025-04-29 2025-04-29 0001868419 us-gaap:SeriesBPreferredStockMember us-gaap:SubsequentEventMember 2025-05-30 0001868419 us-gaap:SubsequentEventMember us-gaap:CommonStockMember us-gaap:SeriesBPreferredStockMember 2025-04-01 2025-05-30 0001868419 us-gaap:SeriesDPreferredStockMember us-gaap:SubsequentEventMember 2025-05-30 0001868419 us-gaap:SubsequentEventMember us-gaap:CommonStockMember us-gaap:SeriesDPreferredStockMember 2025-04-01 2025-05-30 0001868419 us-gaap:SubsequentEventMember CYCU:SeriesAWarrantsMember 2025-04-01 2025-05-30 0001868419 us-gaap:SubsequentEventMember us-gaap:CommonStockMember CYCU:SeriesAWarrantsMember 2025-05-30 0001868419 us-gaap:SubsequentEventMember CYCU:SeriesBWarrantsMember 2025-04-01 2025-05-30 0001868419 us-gaap:SubsequentEventMember CYCU:SeriesBWarrantsMember us-gaap:CommonStockMember 2025-05-30 0001868419 us-gaap:SubsequentEventMember CYCU:SeriesDWarrantsMember 2025-04-01 2025-05-30 0001868419 us-gaap:SubsequentEventMember CYCU:SeriesDWarrantsMember us-gaap:CommonStockMember 2025-05-30 0001868419 us-gaap:SubsequentEventMember 2025-04-01 2025-05-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

     

    FORM 10-Q

     

    ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

     

    For the quarterly period ended March 31, 2025

     

    OR

     

    ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

     

    For the transition period from __________ to __________

     

    Commission File Number: 001-41214

     

     

     

    Cycurion, Inc.

    (Exact name of registrant as specified in its charter)

     

     

     

    Delaware   86-3720717
    (State or other jurisdiction of incorporation or organization)   (I.R.S. Employer Identification No.)
         
    1640 Boro Place, Fourth Floor    
    McLean, Virginia   22102
    (Address of principal executive offices)   (Zip Code)

     

    Registrant’s telephone number, including area code: (888) 341-6680

     

    Former name, former address and former fiscal year, if changed since last report: Western Acquisition Ventures Corp.

     

     

     

    SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT:

     

    Title of Each Class  

    Trading Symbol

      Name of Each Exchange on Which Registered
    Common stock, par value $0.0001 per share   CYCU   The NASDAQ Stock Market LLC
    Redeemable warrants, each exercisable for one share of common stock at an exercise price of $11.50 per share   CYCUW   The NASDAQ Stock Market LLC

     

    Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

     

    Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     

    Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒
    Smaller reporting company ☒ Emerging growth company ☒  

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

    Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒

     

    As of June 5, 2025, there were 31,443,906 shares of common stock outstanding.

     

     

     

     

     

     

    FORWARD-LOOKING STATEMENTS

     

    This quarterly report on Form 10-Q contains “forward-looking statements” within the meaning of Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934 (the “Exchange Act”). Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations, and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy, and other future conditions. This includes, without limitation, statements regarding the financial position and the plans and objectives of management for our future operations. Such statements can be identified by the fact that they do not relate strictly to historical or current facts. When used in this quarterly report on Form 10-Q, words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “strive,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking.

     

    These risks include the risks that are identified in the “Risk Factors” section of this quarterly report and of our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and also include, among others, risks associated with the following:

     

      ● the occurrence of any event, change or other circumstances, including the outcome of any legal proceedings that may be instituted against us;
         
      ● the ability to maintain the listing of our securities on The Nasdaq Stock Market, and the potential liquidity and trading of our securities;
         
      ● the risk of disruption to our current plans and operations;
         
      ● the ability to recognize the anticipated benefits of our business and the recently closed de-SPAC transaction, which may be affected by, among other things, competition and the ability to grow, manage growth profitably, and retain key employees;
         
      ● costs related to our business;
         
      ● changes in applicable laws or regulations;
         
      ● our ability to meet our future capital requirements to fund our operations, which may involve debt and/or equity financing, and to obtain such debt and/or equity financing on favorable terms, and our sources and uses of cash;
         
      ● our ability to achieve and sustain profitability of our existing lines of business and through our wholly owned subsidiaries;
         
      ● our ability to raise sufficient capital to continue to acquire cybersecurity companies;
         
      ● our ability to attract and retain qualified cybersecurity talent;
         
      ● our ability to successfully execute acquisitions, integrate the acquired businesses, and create synergies as a global cybersecurity consolidator;
         
      ● our ability to efficiently acquire customers and maintain high client retention rates;
         
      ● our ability to attract and retain qualified key technology or management personnel and to expand our management team;
         
      ● our ability to stay in compliance with laws and regulations currently applicable to, or which may become applicable to our business both in the United States and internationally;
         
      ● our ability to maintain existing license agreements;
         
      ● our estimates regarding expenses, future revenue, capital requirements, and need for additional financing;
         
      ● our ability to achieve and maintain profitability in the future;
         
      ● our financial performance; and
         
      ● other factors disclosed under the section entitled “Risk Factors” in this quarterly report on Form 10-Q.

     

    These forward-looking statements are based on information available as of the date of this quarterly report on Form 10-Q and current expectations, forecasts, and assumptions, and involve a number of judgments, risks, and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing our views as of any subsequent date, and we do not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events, or otherwise, except as may be required under applicable securities laws.

     

    2
     

     

    Cycurion, Inc.

     

    TABLE OF CONTENTS

     

        Page
    PART I FINANCIAL INFORMATION
         
    Item 1. Financial Statements 4
         
      Consolidated Balance Sheets as of March 31, 2025 (unaudited) and December 31, 2024 4
         
      Consolidated Statements of Operations and Comprehensive Income (Loss) (unaudited) for the three months ended March 31, 2025 and 2024 5
         
      Consolidated Statements of Mezzanine Equity and Stockholders’ Equity (unaudited) for the three months ended March 31, 2025 and 2024 6
         
      Consolidated Statements of Cash Flows (unaudited) for the three months ended March 31, 2025 and 2024 7
         
      Notes to Consolidated Financial Statements (unaudited) 8
         
    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 44
         
    Item 3. Quantitative and Qualitative Disclosures about Market Risks 52
         
    Item 4. Controls and Procedures 52
         
    PART II OTHER INFORMATION 53
    Item 1. Legal Proceedings 53
    Item 1A. Risk Factors 53
    Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 53
    Item 3. Defaults upon Senior Securities 53
    Item 4. Mine Safety Disclosures 53
    Item 5. Other Information 53
    Item 6. Exhibits 54
    Signatures 55

     

    3
     

     

    PART I - FINANCIAL INFORMATION

     

    ITEM 1. FINANCIAL STATEMENTS

     

    CYCURION, INC. AND ITS SUBSIDIARIES

    CONSOLIDATED BALANCE SHEETS

    (UNAUDITED)

     

       March 31,   December 31, 
       2025   2024 
    Assets          
    Current assets          
    Cash  $2,269,195   $38,742 
    Restricted cash   -    2,048 
    Accounts receivable, net   3,937,771    10,353,708 
    Other receivables   403,448    434,391 
    Prepaid expenses and other current assets   110,878    99,463 
    Total current assets  $6,721,292   $10,928,352 
               
    Non-current assets          
    Deposit for acquisition target   -    2,000,000 
    Fixed assets, net   18,612    20,321 
    Software development cost   4,221,981    4,151,981 
    Intangible asset   16,667    25,000 
    Security deposits   10,351    10,351 
    Goodwill   20,538,228    6,592,304 
    Investments held in Trust Account   -    1,834,540 
    Total non-current assets   24,805,839    14,634,497 
               
    Total Assets  $31,527,131   $25,562,849 
               
    Liabilities, Mezzanine and Stockholders’ Equity          
    Current liabilities          
    Bank loan-revolving credit line   3,239,767    3,249,067 
    Bank loan-current portion   770,078    774,095 
    Loans payable - current portion   885,240    408,516 
    Factoring liability   2,176,922    - 
    Subordinated convertible promissory notes   -    3,333,335 
    Convertible notes   390,976    - 
    Promissory notes   3,138,153    2,486,989 
    Loans payable - related parties   149,401    148,088 
    Loans payable   149,401    148,088 
    Accounts payable   5,666,856    3,578,374 
    Due to related party   18,000    - 
    Accrued liabilities   4,228,995    3,601,242 
    Excise tax payable   1,167,173    1,157,161 
    Total current liabilities   21,831,561    18,736,867 
               
    Long-term loan payable   295,296    146,798 
    Series A convertible preferred stock ($0.001 par value, 500,000 shares designated, 0 and 345,528 issued and outstanding)   -    1,294,117 
    Total non-current liabilities   295,296    1,440,915 
               
    Total Liabilities  $22,126,857   $20,177,782 
               
    Commitments and contingencies Note 19   -    - 
               
    Mezzanine Equity          
    Common stock subject to possible redemption, $0.0001 par value, 0 and 173,879 shares at redemption value of approximately $11.03 per share, respectively   -    1,917,309 
               
    Stockholders’ Equity          
    Preferred stock ($0.0001 par value, 20,000,000 shares authorized)          
    Series A convertible preferred stock ($1.45 stated value, 110,000 shares designated, 106,816 and 0 issued and outstanding, respectively)   11    - 
    Series B convertible preferred stock ($1.00 stated value, 3,000 shares designated, 1 and 3,000 issued and outstanding, respectively)   -    - 
    Series C convertible preferred stock ($82.46 stated value, 5,000 shares designated, 4,851 issued and outstanding)   -    - 
    Series D convertible preferred stock ($0.50 stated value, 6,666,700 shares designated, 150,000 and 0 issued and outstanding)   15    - 
    Series E convertible preferred stock ($10,000 stated value, 100 shares designated, 51 and 0 issued and outstanding)   -    - 
    Preferred stock value   -    - 
    Common stock ($0.0001 par value, 100,000,000 shares authorized, 32,068,770 and 10,592,607 shares issued and outstanding)   3,207    1,059 
    Additional paid in capital   26,323,118    6,670,060 
    Accumulated deficit   (13,461,859)   (3,203,361)
    Total Stockholders’ Equity of Cycurion   12,864,492    3,467,758 
               
    Equity attributable to noncontrolling interests   (3,464,218)   - 
    Total Stockholders’ Equity   9,400,274    3,467,758 
               
    Total Liabilities and Stockholders’ Equity  $31,527,131   $25,562,849 

     

    See accompanying notes to the unaudited consolidated financial statements.

     

    4
     

     

    CYCURION, INC. AND ITS SUBSIDIARIES

    CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

    (UNAUDITED)

     

       2025   2024 
       Three months ended 
       March 31, 
       2025   2024 
             
    Net revenues  $3,870,050   $4,242,855 
    Cost of revenues   3,192,287    3,896,141 
    Gross profit   677,763    346,714 
               
    Operating expenses:          
    Selling, general and administrative expenses   10,775,268    378,977 
               
    Operating income (loss)   (10,097,505)   (32,263)
               
    Other income (expenses):          
    Interest expense   (178,890)   (231,475)
    Gain on settlement of debts   141,653    - 
    Other expense   (113,744)   (48,737)
    Other income (expenses)   (150,981)   (280,212)
               
    Income (loss) before income taxes   (10,248,486)   (312,475)
               
    Provision before income taxes   -    - 
               
    Net income (loss)  $(10,248,486)  $(312,475)
    Less: Comprehensive income attributable to noncontrolling interests   -    - 
    Net comprehensive loss attributed to Cycurion  $(10,248,486)  $(312,475)
               
    Comprehensive income (loss)  $(10,248,486)  $(312,475)
               
    Net income (loss) per common share          
    Basic and diluted loss per common share  $(0.56)  $(0.02)
    Diluted loss per common share  $(0.56)  $(0.02)
               
    Basic and diluted weighted average common shares outstanding   18,271,618    14,863,215 
    Diluted weighted average common shares outstanding   18,271,618    14,863,215 

     

    See accompanying notes to the unaudited consolidated financial statements.

     

    5
     

     

    CYCURION, INC. AND ITS SUBSIDIARIES

    CONSOLIDATED STATEMENTS OF MEZZANINE EQUITY AND STOCKHOLDERS’ EQUITY

    (UNAUDITED)

     

       Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   capital   deficit   Total   Interest   Equity 
               Total Cycurion, Inc. Stockholders’ Equity 
      

    Common stock

    subject to possible

      

    Series A

    convertible

      

    Series B

    convertible

      

    Series C

    convertible

      

    Series D

    convertible

      

    Series F

    convertible

                                 
       redemption   preferred stock   preferred stock   preferred stock   preferred stock   preferred stock   Common stock   Additional           Non   Total 
       Number of       Number of       Number of       Number of       Number of       Number of       Number of      

    paid-in

       Accumulated      

    controlling

      

     Stockholders’

     
       Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   capital   deficit   Total   Interest   Equity 
    Balance as of December 31, 2024   173,879   $1,917,309    -   $        -    3,000   $       -    4,851   $       -    -   $-    -   $-    10,592,607   $  1,059.00   $6,670,060   $(3,203,361)  $  3,467,758.00   $-   $3,467,758.00 
                                                                                                    
    Common stocks redeemed (Mezzanine Equity)   (94,896)   (1,001,216)                                                                                     
    Release of common stock subject to redemption   (78,983)   (916,093)   -    -    -    -    -    -    -    -    -    -    78,983    8    916,085    -    916,093    -    916,093 
    Series A preferred stock in exchange of Series A Preferre Stock categorized as liability   -    -    106,816    11    -    -    -    -    -    -    -    -    -    -    1,391,165    -    1,391,176    -    1,391,176 
    Series D preferred stock in exchange of convertible notes   -    -    -    -    -    -    -    -    6,666,666    667    -    -    -    -    3,332,668    -    3,333,335    -    3,333,335 
    Common stock issued for conversion of Series B and D Preferred Stock   -    -    -    -    (2,999)   -    -    -    (6,516,666)   (652)   -    -    12,515,319    1,252    (600)   -    -    -    - 
    Common stock issued for exercise of warrants   -    -    -    -    -    -    -    -    -    -    -    -    7,044,917    704    3,309,217    -    3,309,921    -    3,309,921 
    Common stock issued for business combination costs   -    -    -    -    -    -    -    -    -    -    -    -    750,000    75    8,999,925    -    9,000,000    -    9,000,000 
    Common stock issued for settleemnt of liability   -    -    -    -    -    -    -    -    -    -    -    -    78,803    8    945,628    -    945,636    -    945,636 
    Common stock issued for employment agreement   -    -    -    -    -    -    -    -    -    -    -    -    500,000    50    249,950    -    250,000    -    250,000 
    Acquisiton of subsidiary   -    -    -    -    -    -    -    -    -    -    51    -    508,141    51.00    509,020    -    509,071    (3,464,218)   (2,955,147)
    Excise tax liability arising from redemption of Class A shares   -    -    -    -    -    -    -    -    -    -    -    -    -    -    -    (10,012)   (10,012)   -    (10,012)
    Net loss   -    -    -    -    -    -    -    -    -    -    -    -    -    -    -    (10,248,486)   (10,248,486)   -    (10,248,486)
    Balance as of March 31, 2025   -   $-    106,816   $11    1   $-    4,851   $-    150,000   $15    51   $-    32,068,770   $3,207   $26,323,118   $(13,461,859)  $12,864,492   $(3,464,218)  $9,400,274 

     

       Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   capital   deficit   Equity 
               Total Cycurion, Inc. Stockholders’ Equity 
      

    Common stock

    subject to

    possible

      

    Series A

    convertible

      

    Series B

    convertible

      

    Series C

    convertible

      

    Series D

    convertible

      

    Series F

    convertible

                         
       redemption   preferred stock   preferred stock   preferred stock   preferred stock   preferred stock   Common stock   Additional       Total 
       Number of       Number of       Number of       Number of       Number of       Number of       Number of      

    paid-in

       Accumulated  

    Stockholders’

     
       Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   capital   deficit   Equity 
    Balance as of December 31, 2023       -           -         -           -    2,000   $      -    4,851   $      -         -            -           -           -    7,341,607   $734   $  9,678,339   $  (4,432,962)  $5,246,111 
    Balance       -           -         -           -    2,000   $      -    4,851   $      -         -            -           -           -    7,341,607   $734   $  9,678,339   $  (4,432,962)  $5,246,111 
    Board Compensation   -    -    -    -    -    -    -     -     -    -    -    -    -    -    10,000    -    10,000 
    Net loss   -    -    -    -    -    -              -    -    -    -    -    -    -    (312,475)   (312,475)
    Balance as of March 31, 2024   -   $-    -   $-    2,000   $-    4,851   $-    -   $-   -   $-    7,341,607   $734   $9,688,339   $(4,745,437)   4,943,636 
    Balance   -   $-    -   $-    2,000   $-    4,851   $-    -   $-   -   $-    7,341,607   $734   $9,688,339   $(4,745,437)   4,943,636 

     

    See accompanying notes to the unaudited consolidated financial statements.

     

    6
     

     

    CYCURION, INC. AND ITS SUBSIDIARIES

    CONSOLIDATED STATEMENTS OF CASH FLOWS

    (UNAUDITED)

     

       2025   2024 
       Three months ended 
       March 31, 
       2025   2024 
    Cash flows from operating activities          
    Net income (loss)  $(10,248,486)  $(312,475)
    Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:          
    Stock based compensation   9,250,000    10,000 
    Amortization of debt discount   64,850    - 
    Depreciation of fixed assets   1,709    2,197 
    Amortization of software development cost   8,333    - 
    Loss on settlement   (141,653)   - 
    Finance expense   100,000    - 
    Changes in operating assets and liabilities:          
    Accounts and other receivables   (1,300,686)   (507,077)
    Prepaid and other current assets   (11,415)   4,928 
    Accounts and accrued liabilities   (467,761)   529,981 
    Net cash used in operating activities   (2,745,109)   (272,446)
               
    Cash flows from investing activities          
    Cash acquired on acquisition of subsidiary   34,983    - 
    Purchase of plant and equipment   (70,000)   (105,001)
    Cash withdrawn from Trust Account in connection with redemption   1,001,216    - 
    Release of Trust Account to Company’s bank account   833,324    - 
    Net cash from (used in) investing activities   1,799,523    (105,001)
               
    Cash flows from financing activities          
    Proceeds from exercise of warrants   3,309,921    - 
    Redemption of common stock subject to redemption   (1,001,216)   - 
    Net proceeds from line of credit   (9,300)   (16,980)
    Repayment of all bank borrowings   (5,114)   (6,503)
    Proceeds from convertible notes payable   386,500    - 
    Proceeds from notes payable   513,200    - 
    Repayments of notes payable   (20,000)   - 
    Net cash provided by (used in) financing activities   3,173,991    (23,483)
               
    Net change in cash and restricted cash   2,228,405    (400,930)
    Cash –beginning of period   40,790    607,869 
    Cash–end of period  $2,269,195   $206,939 
               
    Supplementary cash flow information:          
    Income taxes paid  $-   $- 
               
    Non-cash investing and financing activity          
    Share exchange of Series A Preferred Stock for reverse acquisition  $1,391,176   $- 
    Series D preferred stock in exchange of convertible notes  $3,333,335   $- 
    Common stock issued for conversion of Series B and D Preferred Stock  $1,252   $- 
    Common stock and Series F Preferred Stock issued for acquisition of subsidiary  $509,071   $- 
    Excise tax liability arising from redemption of common stock subject to redemption  $10,012   $- 
    Release of common stock subject to redemption  $916,093   $- 

     

    See accompanying notes to the unaudited consolidated financial statements.

     

    7
     

     

    CYCURION, INC. AND ITS SUBSIDIARIES

    NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

    As of and for the three months ended March 31, 2025 and 2024

     

    NOTE 1 — ORGANIZATION AND DESCRIPTION OF BUSINESS

     

    Description of Business

     

    Cycurion, Inc (f/k/a KAE Holdings, Inc.; f/k/a Cyber Secure Solutions, Inc.; the “Company”, “Cycurion”,“we”, “us” or “our”) was incorporated on October 12, 2017, in the state of Delaware. Through its subsidiaries, the Company provides premier information technology security solutions. The Company continually strives to deliver top-notch services in the areas of risk management, cybersecurity, information assurance, systems engineering and help desk solutions. The Company is headquartered in McLean, Virginia. On July 14, 2020, the Company changed its corporate name from KAE Holdings, Inc. to Cyber Secure Solutions, Inc., and, on February 24, 2021, to Cycurion, Inc.

     

    On November 22, 2017, the Company acquired Axxum Technologies, LLC (“Axxum”), a limited liability company organized on December 29, 2006, in the Commonwealth of Virginia.

     

    On April 3, 2019, the Company acquired Cloudburst Security, LLC (“Cloudburst”), a limited liability company organized on January 12, 2007, in the Commonwealth of Virginia.

     

    Business Combination

     

    On February 14, 2025, we completed the business combination and transactions (the “Business Combination”) as set forth in an Agreement and Plan of Merger, dated November 21, 2022, as amended on April 26, 2024, December 31, 2024 and February 13, 2025 (the “Merger Agreement”), by and among Western Acquisition Ventures Corp. (“Western”), Western Acquisition Merger Inc., a Delaware corporation and a wholly-owned subsidiary of Western (“Merger Sub”), and Cycurion Sub, Inc., a Delaware corporation formerly known as Cycurion, Inc. (“Cycurion Sub”). As contemplated by the Merger Agreement, Merger Sub merged with and into Cycurion Sub with Cycurion Sub as surviving the merger as a wholly-owned subsidiary of Western. In addition, in connection with the consummation of the Business Combination, Western was renamed “Cycurion, Inc.”

     

    On February 14, 2025, the parties completed the Business Combination. As a result of the Business Combination, each ordinary share of Cycurion Sub was cancelled and converted into shares of Company common stock, on the terms set forth in the Merger Agreement. Pursuant to the terms of the Merger Agreement, the aggregate number of shares of Company common stock that was delivered as consideration in the Business Combination was capped at 15,000,000 shares. Concurrently with the completion of the Business Combination, the Company issued an aggregate of 6,543,073 shares of common stock, 106,816 shares of Series A preferred stock (“Class A Convertible Preferred Stock”), 3,000 shares of Series B preferred stock (“Class B Convertible Preferred Stock”), 4,851 shares of Series C preferred stock (“Class C Convertible Preferred Stock”), 6,666,667 shares of Series D preferred stock (“Class D Convertible Preferred Stock”), 680,875 Series A warrants, 6,000,000 Series B warrants, 7,272,728 Series D warrants , 270,171 common stock warrants, 472,813 shares of common stock issued in connection with the Series D private placement, 500,000 shares of common stock issued to A.G.P./Alliance Global Partners (“A.G.P.”), 250,000 shares of common stock issued to Seward & Kissel LLP and 78,803 shares of common stock issued to Baker & Hostetler LLP.

     

    8
     

     

    The Business Combination has been accounted for as a reverse recapitalization in accordance with U.S. GAAP because Cycurion is the operating company and has been determined to be the accounting acquirer under Financial Accounting Standards Board’s Accounting Standards Codification Topic 805, Business Combinations (“ASC 805”), while Western is a blank check company.

     

    Under the reverse recapitalization model, the Business Combination was treated as Cycurion issuing equity for the net assets of Western, with no goodwill or intangible assets recorded.

     

    While Western was the legal acquirer in the Business Combination, because Cycurion, prior to the Business Combination (“Predecessor Cycurion”), was deemed the accounting acquirer, the historical financial statements of Predecessor Cycurion became the historical financial statements of the combined company upon the consummation of the Business Combination. As a result, the financial statements reflect (i) the historical operating results of Predecessor Cycurion prior to the Business Combination; (ii) the combined results of Western and Predecessor Cycurion following the closing of the Business Combination; (iii) the assets and liabilities of Predecessor Cycurion at their historical cost; and (iv) Cycurion’s equity structure for all periods presented.

     

    In accordance with the applicable guidance, the equity structure has been retroactively restated in all comparative periods up to the Closing Date, to reflect the number of shares of the Company’s common stock issued to Predecessor Cycurion common stockholders in connection with the Business Combination. As such, the shares and corresponding capital amounts and earnings per share related to Predecessor Cycurion prior to the Business Combination have been retroactively restated as shares reflecting the exchange ratio established in the Business Combination.

     

    Going Concern

     

    The accompanying financial statements have been prepared in conformity with generally accepted accounting principles (“GAAP”) in the United States, which contemplates continuation of the Company on a going concern basis. The going concern basis assumes that assets are realized, and liabilities are settled in the ordinary course of business at amounts disclosed in the financial statements. As of March 31, 2025, there was substantial doubt regarding the Company’s ability to continue as a going concern, as the Company had a net working capital deficit and an accumulated deficit resulting from substantial losses incurred during the three months ended March 31, 2025 and from prior periods. The Company’s ability to continue as a going concern depends upon its ability to market and sell its products to generate positive operating cash flows. As of March 31, 2025, the Company had an accumulated deficit of $13.4 million and a working capital deficit of $15.1 million. In addition, the Company had a net cash outflow of $2.8 million from operating activities during the three months ended March 31, 2025. These circumstances continued to give rise to substantial doubt as to whether the Company will be able to continue as a going concern and did not alleviate the doubt outstanding from 2024.

     

    Management’s plan is to continue improve operations to generate positive cash flows and register shares of its common stock in order to undertake a public offering to raise additional capital. Management believes that the valuation and liquidity brought by a public offering of its securities will allow holders of convertibles notes, and convertible preferred stockholders the mechanism to convert their securities into common stock that will reduce the Company’s overall leverage and debt service requirement. If the Company is not able to continue generating positive operating cash flows, and raise additional capital, there is the risk that the Company may become insolvent.

     

    9
     

     

    Restricted Cash

     

    In accordance with the trust agreement between Western and Equiniti Trust Company, LLC, dated January 11, 2022, the Company is permitted to withdraw interest from the trust account (the “Trust Account”) to pay its tax obligations, including federal income taxes and state franchise taxes. The balance of this withdrawal is included in restricted cash in the amount of $0 on the accompanying balance sheet, representing the amounts available exclusively for payment of current tax liabilities.

     

    NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

     

    Basis of presentation

     

    The accompanying unaudited consolidated condensed financial statements are presented in conformity with generally accepted accounting principles in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP for audited financial statements. In the opinion of management, the unaudited consolidated condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. The interim results for the three months ended March 31, 2025 are not necessarily indicative of the results to be expected for the year ended December 31, 2025 or for any future interim periods.

     

    The accompanying unaudited consolidated condensed financial statements should be read in conjunction with the Company’s audited financial statements and notes thereto, included in the Annual Report on Form 10-K filed with the U.S. Securities and Exchange (“SEC”) on April 17, 2025.

     

    Principles of consolidation

     

    These financial statements include the accounts of Cycurion, Inc. (f/k/a KAE Holdings, Inc.; f/k/a Cyber Secure Solutions, Inc.) and its wholly owned subsidiaries: Axxum Technologies, LLC (“Axxum”), Cloudburst Security, LLC (“Cloudburst”), Cycurion Innovation, Inc. (“Cycurion Innovation”), Western, and SLG Innovation Inc (“SLG”). All significant inter-company balances, fees, and expenses have been eliminated in consolidation.

     

    Segment Information

     

    Our Chief Executive Officer (“CEO”) is the chief operating decision maker who reviews financial information on a consolidated basis for purposes of allocating resources and evaluating financial performance. Accordingly, we determined we operate in a single reporting segment.

     

    Our CEO assesses performance and decides how to allocate resources primarily based on consolidated net income, which is reported on our Consolidated Statements of Operations. Total assets on the Consolidated Balance Sheets represent our segment assets.

     

    Reclassification

     

    Certain amounts have been reclassified to improve the clarity and comparability of the financial statements. These reclassifications had no impact on previously reported total assets, liabilities, equity, net income (loss), or cash flows for any periods presented.

     

    10
     

     

    Emerging Growth Company

     

    The Company is an emerging growth company as defined in Section 102(b)(1) of the Jumpstart Our Business Start-ups Act of 2012 (the “JOBS Act”) which exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies, but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised, and it has different application dates for public or private companies. The Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.

     

    This may make comparison of the Company’s financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

     

    Use of estimates

     

    The preparation of financial statements in conformity with GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, and disclosures regarding contingent liabilities at the date of the financial statements. These estimates may affect the reported amounts for certain revenues and expenses incurred during the reporting period; actual results may materially differ from these estimates.

     

    Cash and Cash Equivalents and Restricted Cash

     

    Cash and cash equivalents include cash on hand, deposits in banks, and any investments with maturities with less than three months from inception to maturity. The Company’s primary bank deposits are located in the United States. Those deposits are provided protection under the Federal Deposit Insurance Corporation (“FDIC”) up to maximum of $250,000. The amount in excess of the FDIC insurance as of March 31, 2025 was approximately $1.6 million. Management has determined that the risk of loss from insolvency by the financial institutions at which it has deposited it funds is insignificant and unlikely; accordingly, the Company has not accrued for any potential losses.

     

    The Company had $2,269,195 and $38,742 in cash and did not have any cash equivalents as of March 31, 2025 and December 31, 2024, respectively. As of March 31, 2025 and December 31, 2024, the Company also had $0 and $2,048 of restricted cash, respectively, related to funds withdrawn from the Trust Account reserved for the payment of income and state franchise taxes.

     

    Common Stock subject to Possible Redemption

     

    The Company accounts for its common stock subject to possible redemption in accordance with the guidance in ASC 480. Shares of common stock subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s shares of common stock sold in the initial public offering of Western feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events.

     

    11
     

     

    As of March 31, 2025 and December 31, 2024, the value of common stock subject to possible redemption reflected on the balance sheet is reconciled on the following table:

     

    SCHEDULE OF COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION

    Common stock subject to possible redemption as of December 31, 2024  $1,917,309 
    Less:     
    Redemption   (1,001,216)
    Release of common stock subject to redemption   (916,093)
    Common stock subject to possible redemption as of March 31, 2025   - 

     

    Accounts receivable

     

    Accounts receivable is stated at the original amount less an allowance for credit losses.

     

    Accounts receivable is recognized in the period when the Company has provided services to its customers and when its right to consideration is unconditional. ASC 326 introduces an approach based on expected losses to estimate the allowance for doubtful accounts, which replaces the previous incurred loss impairment model. The Company’s estimation of allowance for credit losses considers factors such as historical credit loss experience, age of receivable balances, subsequent collection, current market conditions, reasonable and supportable forecasts of future economic conditions.

     

    The Company evaluates its accounts receivable for expected credit losses on a regular basis. The Company maintains an estimated allowance for credit losses to reduce its accounts receivable to the amount that it believes will be collected. The Company considers factors in assessing the collectability of its receivables, such as the age of the amounts due, the customer’s payment history, credit-worthiness and other specific circumstances related to the accounts. If there is strong evidence indicating that the accounts receivable is likely to be unrecoverable, the Company also makes specific allowance in the period in which a loss is determined to be probable. Accounts receivable balances are written off after all collection efforts have been exhausted.

     

    The Company also assessed the creditworthiness and solvency of its customers as of March 31, 2025 and December 31, 2024 and has determined that those customers were unlikely not to settle their balances in full; accordingly, as of March 31, 2025 and December 31, 2024, the Company’s estimated allowance for credit losses was both zero.

     

    Property, plant, and equipment

     

    Equipment is carried at cost less accumulated depreciation. Depreciation is provided over their estimated useful lives, using the straight-line method. Estimated useful lives of the equipment are as follows:

     SCHEDULE OF ESTIMATED USEFUL LIVES OF RELATED ASSETS

    Office equipment   3 years
    Furniture and fixtures   5 years
    Leasehold improvement   Co-terminal with lease
    Capital lease   1 year
    Software   3 years

     

    The cost of maintenance and repairs to fixed assets are charged to expenses as incurred.

     

    Goodwill

     

    Goodwill represents the excess of the purchase price over the fair value of the net tangible and identifiable assets acquired in a business combination. Goodwill is reviewed for impairment annually during the fourth quarter of each fiscal year, or more frequently if impairment indicators arise. The review of goodwill impairment consists of either using a qualitative approach to determine whether it is more likely than not that the fair value of the assets is less than their respective carrying values or a one-step quantitative impairment test. In performing the qualitative assessment, we consider many factors in evaluating whether the carrying value of goodwill may not be recoverable. If, based on the results of the qualitative assessment, it is concluded that it is not more likely than not that the fair value of a reporting unit exceeds its carrying value, additional quantitative impairment testing is performed. The quantitative test requires that the carrying value of each reporting unit be compared with its estimated fair value. If the carrying value of a reporting unit is greater than its fair value, a goodwill impairment charge will be recorded for the difference (up to the carrying value of goodwill). Fair value is generally determined using a discounted cash flow analysis. During the three months ended March 31, 2025 and 2024, no impairment of goodwill was recognized.

     

    12
     

     

    Software development costs

     

    The Company is undergoing new Software as a Service (“SaaS”) product development based on an acquired SaaS platform in previous years, which has not been utilized in its original form. Cost from the acquired SaaS platform, functionalities and modules and the redesigned features of the distinct new SaaS product are accounted for under ASC 985-20 (Costs of Software to Be Sold, Leased, or Marketed). Development costs were capitalized as “Software Development in Progress” after achieving technological feasibility.

     

    Accounting for long-lived assets

     

    The Company annually reviews its long-lived assets for impairment or whenever events or changes in circumstances indicate that the carrying amount of assets may not be recoverable. Impairment may be the result of becoming obsolete from a change in the industry or new technologies. Impairment is present if the carrying amount of an asset is less than its undiscounted cash flows to be generated.

     

    If an asset is considered impaired, a loss is recognized based on the amount by which the carrying amount exceeds the fair market value of the asset. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.

     

    Bank loans

     

    The Company accounts for borrowings from banks as either current or long-term borrowings. Origination and closing costs for long term borrowings are accounted for using the effective interest method and accreted to the Company’s outstanding balances owed over the life of the long-term loan, and the related interest expense is recognized to the results of operations.

     

    Revenue recognition

     

    The Company adopted ASC Topic 606, Revenue from Contracts with Customers. Revenue from contracts with customers is recognized using the following five steps:

     

      1. Identify the contract(s) with a customer;
      2. Identify the performance obligations in the contract;
      3. Determine the transaction price;
      4. Allocate the transaction price to the performance obligations in the contract; and
      5. Recognize revenue when (or as) the entity satisfies a performance obligation.

     

    In applying ASC 606, the Company will recognize revenue when the Company has negotiated and formalized the terms of the transaction in the form of written contracts with their customers that set forth the sales price, the scope of services to be delivered by professional technology infrastructure and cyber engineers measured in hours, accompanied by hourly billing rates, and payment terms; typically, the performance obligations in the contract are the delivery of service hours; when the Company has obtained evidence that the service has been delivered and the performance obligations have been fulfilled, it will record revenue and either recognize an asset such as accounts receivable or decrease deferred revenue from its liabilities.

     

    13
     

     

    Management has determined that its services business can be segregated into four lines of business. Each line of business has its own methodology for recognizing revenue.

     

    Advisory Consulting

     

    The Company enters into service agreements with customers that will set forth the responsibilities of both parties, including the type of service to de delivered, the timing of the delivery of those services, and the associated price per unit for such services. The unit of measure in the agreement is typically hours. The advisory consulting services represent a single performance obligation, as they constitute a series of distinct hourly services that are substantially the same and transferred to the customer over time. The revenue from advisory service agreement will also set forth the timing of payments by the customers which is typically between 60 and 90 days from the date that an invoice is issued to the customer. The Company issues invoices when management has received acknowledgment from the customer that it has rendered service as measured in hours to the customer. As a practical matter, the Company continuously delivers service to customers, and the customer receives benefits from those services over time. The revenue advisory consulting is recognized over time as services are rendered, based on contractual hourly rates, and when the Company has received the aforementioned acknowledgement from its customers that service has been rendered related to hours accumulated over period of time, such as a week, or two weeks, or a month, which is determined on a customer by customer basis. The Company’s contracts do not include terms for returns, or warranties, or guarantees, or rebates, or discounts on the services rendered. The company also enters into annual contracts with customers to provide ongoing advisory and consulting services. Services are delivered continuously over the contract term and customers are billed periodically. The annual service contract represents a single performance obligation because the services are a series of distinct, substantially similar acts that are inseparable and transferred over time. Revenue is recognized over time straight-line over the contract term.

     

    Managed Security Service Practice (MSSP)

     

    Management has determined that its managed security service practice is a bundle of cybersecurity software tools, and expert 24x7x365 monitoring and breach resolution service that is accounted for as a single performance obligation that is delivered over time which is typically a month; the components of the bundle have individual commercial value; however, management believes assigning stand-alone value to each component is impractical because each component would not be able to be fully implemented or utilized if not packaged with the other components; therefore, management believes the MSSP can only be sold as a bundle package over time. At the time that the Company recognizes revenue it is has either already received funds in advance from its customer, or it is reasonably assured that it will collect funds from its customer; in the event that funds that are received in advance, they are accounted for as contract liabilities in the deferred revenue account until the Company fulfills the performance obligation; a majority of the Company’s contracts call for the Company to first deliver service and collect fees thereafter; the Company typically receives payment for these contracts within thirty to ninety days of delivery of service. The Company does not sell monitoring time, security software-tools, and breach resolution as stand-alone services, as the customer would not receive the benefits of these items if they were not sold as an integrated package. The cybersecurity needs to monitor the customer cybersecurity environment regularly, stay up to date on cyberthreats and solutions, maintain its software tools, and then address threats identified, or rectify situations when customer environments have been breached. It is not practical or viable to sell these components separately, as customers expect comprehensive solutions. While the components are separately identifiable, management does not believe they could market the components individually. The Company’s management does not believe their customers can benefit from the individual components alone, and there are not readily available resources in the market that can be obtained to make those components viable. The continuous monitoring allows the Company to identify and either neutralize and or rectify breaches by having up to the minute first-hand information, and the tools allow the Company to implement solutions rapidly; the absence all of the components would render the solutions and service offering significantly devalued and non-competitive in the marketplace.

     

    14
     

     

    The Company believes MSSP meets the criteria to combine the goods and services under a single performance obligation. The Company believes combined integrated solution is delivered continuously over a period of time; in accordance with the terms of the contract between the Company and its customers, the Company receives prepayments in advance from its customers, and recognizes those payments to revenues over a period of time, which is typically each month.

     

    Managed Service Provider (MSP)

     

    The Company’s managed service provider (MSP) service offering is the provision of IT infrastructure support to customers, specifically in the areas of desktop support, on-site troubleshooting, and cloud-based network infrastructure troubleshooting. This service is accounted for as a single performance obligation that is delivered over time, which is typically a month; At the time that the Company recognizes revenue, it either already received funds in advance from its customer, or it is reasonably assured that it will collect funds from its customer; in the event that funds that are received in advance, they are accounted for as contract liabilities in the deferred revenue account until the Company fulfills the performance obligation; a majority of the Company’s contracts call for the Company to first deliver service and collect fees thereafter; the Company typically receives payment for these contracts within thirty to ninety days of delivery of service.

     

    MSP requires the integration of tools and labor in order for a customer to receive any benefit from the services provided. The Company refers to the guidance in ASC 606-10-25-19 to provide an analysis regarding this accounting recognition of this integrated service. Under MSP, the customer cannot receive any benefit purely from labor or individual software tools as a stand-alone service. The tools that the Company deploys require engineers to decipher results and develop solutions to problems during the service period covered in a contract.

     

    While components can be separately identified, they must be used in conjunction with each other to serve the Company’s customers. The Company must continuously make available support engineers to customers whenever they need support and troubleshooting. The service includes remote resolution of issues or going onsite to customer locations to solve problems. The Company’s contracts with customers require the Company to have these resources available during the length of the contract; therefore, these services are continuously delivered as a service over time; accordingly, the Company recognizes revenue for such MSP contract on a monthly basis.

     

    Software as a service (SaaS)

     

    Management has determined that its software as a service is a suite of cybersecurity tools that are delivered either remotely or on customer premises. The service is delivered on a monthly basis. The cybersecurity tools are typically sold as a package; however, the individual components of the suite of tools can either be sold individually or bundled together. Nevertheless, if they are sold individually, or as a bundle, they are all delivered over time; accordingly, the Company recognizes revenue over time, which is typically monthly; At the time that the Company recognizes revenue it is has either already received funds in advance from its customer, or it is reasonably assured that it will collect funds from its customer; in the event that funds that are received in advance, they are accounted for as contract liabilities in the deferred revenue account until the Company fulfills the performance obligation ; a majority of the Company’s contracts call for the Company to first deliver service and collect fees thereafter; the Company typically receives payment for these contracts within thirty to ninety days of delivery of service.

     

    15
     

     

    The Company’s SaaS is delivered continuously over time; it is a subscription service where the Company provisions a suite of security software tools to its customers accessed via the internet that allows the customers to protect themselves from cyber-attacks using multiple tools within the suite. This subscription service is recognized to revenue monthly.

     

    The Company’s disaggregated revenues for the three months ended March 31, 2025 and 2024 were as follows:

     

    SCHEDULE OF DISAGGREGATED REVENUES

       2025   2024 
       Three Months Ended 
       March 31, 
       2025   2024 
             
    Advisory Consulting  $3,835,414   $4,220,436 
    Managed Security Service Practice (MSSP)   31,513    18,747 
    Software as a Service (Saas)   3,123    3,672 
    Revenues  $3,870,050   $4,242,855 

     

    Cost of revenue

     

    Cost of revenue primarily consists of compensation expenses for program personnel, and the fringe benefits associated with this compensation, subcontractor costs, and other direct expenses incurred to deliver services to customers.

     

    Selling, general, and administrative expenses

     

    Selling, general and administrative expenses are expensed as incurred.

     

    Income taxes

     

    The Company accounts for income tax using an asset and liability approach and allows for recognition of deferred tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. A valuation allowance is provided for deferred tax assets if it is more likely than not these items will either expire before the Company is able to realize their benefits, or that future realization is uncertain.

     

    Earnings per share

     

    The Company computes earnings per share (“EPS”) in accordance with ASC Topic 260, “Earnings per share”. Basic EPS is measured as the income or loss available to common stockholders divided by the weighted average number of common shares outstanding for the period. Diluted EPS is similar to basic EPS but presents the dilutive effect on a per-share basis of potential common shares (e.g., convertible securities, options, and warrants) as if they had been converted at the beginning of the periods presented, or issuance date, if later. Potential common shares that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS.

     

    16
     

     

    As of March 31, 2025, common stock equivalents were excluded from the computation of diluted net loss per share as the result of the computation was anti-dilutive (see Note 18).

     

    Commitments and contingencies

     

    Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment can be reasonably estimated.

     

    Comprehensive income

     

    Comprehensive income is defined to include all changes in equity except those resulting from investments by owners and distributions to owners. Among other disclosures, all items that are required to be recognized under current accounting standards as components of comprehensive income are required to be reported in a financial statement that is presented with the same prominence as other financial statements. The Company’s current component of other comprehensive income includes the foreign currency translation adjustment and unrealized gain or loss.

     

    Accounting for Warrants

     

    The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the instruments’ specific terms and applicable authoritative guidance in ASC 480 and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the instruments are free standing financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the instruments meet all of the requirements for equity classification under ASC 815, including whether the instruments are indexed to the Company’s own common shares and whether the instrument holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, was conducted at the time of warrant issuance and as of each subsequent period end date while the instruments are outstanding. Management has concluded that the Public Warrants, Private Placement Warrants, and all other warrants issued qualify for equity accounting treatment.

     

    Recently Issued Accounting Pronouncements

     

    In November 2024, the FASB issued ASU 2024-03, Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, requiring public entities to disclose additional information about specific expense categories in the notes to the financial statements on an interim and annual basis. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and for interim periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2024-03.

     

    In March 2024, the FASB issued ASU 2024-02 “Codification Improvements – Amendments to Remove References to the Concepts Statements” (“ASU 2024-02”), which contains amendments to the Codification to remove references to various FASB Concepts Statements. In most instances, the references are extraneous and not required to understand or apply the guidance. Generally, ASU 2024-02 is not intended to result in significant accounting changes for most entities. ASU 2024-02 is effective for the Company for fiscal years beginning after December 15, 2024. The Company does not expect this update to have a material impact on its financial statements.

     

    In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires, among other things, additional disclosures primarily related to the income tax rate reconciliation and income taxes paid. The expanded annual disclosures are effective for our year ending December 31, 2025. The Company is currently evaluating the impact that ASU 2023-09 will have on the consolidated financial statements and whether the Company will apply the standard prospectively or retrospectively.

     

    17
     

     

    The Company has considered all other recently issued accounting pronouncements and does not believe the adoption of such pronouncements will have a material impact on its financial statements.

     

    NOTE 3 — ACCOUNTS RECEIVABLES

     

    Accounts receivables consisted of the following As of March 31, 2025 and December 31, 2024:

     SCHEDULE OF ACCOUNTS RECEIVABLES

       March 31,   December 31, 
       2025   2024 
    Gross accounts and other receivables  $3,937,771   $10,353,708 
    Less: Allowance for doubtful accounts   -    - 
    Accounts receivables, net  $3,937,771   $10,353,708 

     

    During the three months ended March 31, 2025 and 2024, the Company have not written off any outstanding receivable.

     

    NOTE 4 — BUSINESS COMBINATION

     

    SLG Innovation, Inc.

     

    SLG is a technology services firm with operations and client contracts deemed to be strategically complementary to the Company’s existing business and long-term growth objectives. As of December 31, 2020, the Company had initiated discussions regarding the potential acquisition of SLG Innovation, Inc. (“SLG”) and had advanced a non-refundable deposit of $1,401,923 for cash advances, loans, capitalized transaction costs and accounts receivable arising from prior business dealings with SLG. On May 13, 2021, the Company entered into an agreement to acquire substantially all of SLG’s assets and certain liabilities, which included a termination right exercisable at the Company’s sole discretion prior to December 31, 2021. This agreement was subsequently amended to limit the acquisition to certain specified assets, primarily identifiable sales contracts.

     

    As of December 31, 2024, the refundable deposit had increased to $2,000,000, comprising $561,808 in cash advances and loans, $20,000 in due diligence costs, and $1,418,192 in accounts receivable.

     

    On April 29, 2023, the Company and SLG executed a unidirectional letter of intent (“SLG LOI”), which bound SLG to the transaction but did not obligate the Company. The SLG LOI provided that, unless terminated by the Company on or before April 30, 2024, the Company would proceed to acquire SLG or substantially all of its assets and liabilities through a structure to be finalized. The agreed-upon valuation included the $2,000,000 receivable, $2,136,445 in SLG payables to RCR Technology Corporation (excluding payables incurred within 90 days prior to closing), and 996,355 shares of the Company’s capital stock.

     

    In connection with the SLG transaction, the Company also entered into a separate unidirectional letter of intent with RCR (“RCR LOI”) on April 29, 2023, under which the Company would acquire SLG’s payables owed to RCR, subject to the closing of the SLG transaction. Consideration for the RCR transaction was to be settled in the form of Company shares, as specified in the RCR LOI.

     

    18
     

     

    On March 31, 2025, the company entered into a Management Services Agreement and a Release agreement (the “Agreement”) to acquire certain assets and assumed certain liabilities to acquire 51% of equity interest in SLG. The total purchase consideration related to acquisition of SLG consisted primarily of:

     

    a. prepaid deposit of $2,000,000;

    b. 508,141 shares of common stock having par value of $0.0001 per share; and

    c. 51 shares of Series E Preferred stock with a face value of $10,000 and conversion price of $1.00.

    d. $10,814,147 of accounts receivable in Cycurion owing from SLG

     

    The Company has determined that the SLG acquisition constitutes a business combination as defined by ASC 805, Business Combinations (“ASC 805”). ASC 805 establishes principles and requirements as to how the acquirer of a business recognizes and measures in its financial statements the identifiable assets acquired, the liabilities assumed and any non-controlling interest in the acquiree. The assets acquired and liabilities assumed are recognized provisionally in the accompanying consolidated balance sheets at their estimated fair values as of March 31, 2025. The initial accounting for the business combination is not complete as the Company is in the process of obtaining additional information for the valuation of acquired assets and liabilities, if any. The provisional amounts are subject to change to the extent that additional information is obtained about the facts and circumstances that existed as of the acquisition date. Under U.S. GAAP, the measurement period shall not exceed one year from the acquisition date and the Company will finalize these amounts no later than March 31, 2026. The estimated fair values as of the acquisition date are based on information that existed as of the acquisition date. During the measurement period the Company may adjust provisional amounts recorded for assets acquired and liabilities assumed to reflect new information that the Company has subsequently obtained regarding facts and circumstances that existed as of the acquisition date.

     

    The following table summarizes the fair value of cash and non-cash consideration transferred, assets acquired, liabilities assumed as of the acquisition date, resulting in the bargain purchase gain:

     

    SCHDEULE OF FAIR VALUE OF CONSIDERATION TRANSFERRED ASSETS ACQUIRED LIABILITIES ASSUMED

       Valuation as of 
       March 31, 2025 
    Cash Consideration  $2,000,000 
    Noncash Consideration:     
    Common Stock (1)   254,071 
    Series E Preferred Stock(2)    255,000 
    Account receivables in Cycurion owing from SLG(3)   10,814,147 
    Total Noncash Consideration:  $11,323,218 
    Total Consideration  $13,323,218 

     

     

    (1)Represents the fair value of 508,141 common stock issued in the SLG transaction based on the quoted stock price on the date of issuance.
    (2)Represents the fair value of the Series E Convertible Preferred Stock as is converted to common stock based on the quoted price common stock on the date of issuance.

    (3)

     

    Represents the fair value of the accounts receivable in Cycurion owing from SLG.

     

       Valuation as of 
       March 31, 2025 
    Total consideration:  $13,323,218 
          
    Assets acquired     
    Cash and cash equivalents  $34,983 
    Accounts receivable   3,066,581 
    Assets acquired  $3,101,564 
    Labilities assumed     
    Accounts payable  $4,317,052 
    Accrued liability   10,650 
    Payroll liability   40,642 
    Factoring liability   2,176,922 
    Due to RP   18,000 
    Loans payable   625,222 
    Liabilities to Cycurion   2,982,908 
    Liabilities assumed  $10,171,396 
    Net liability   (7,069,832)
          
    Elimination of inter-company balances     
    Elimination of liabilities in SLG   2,982,908 
    Elimination balance total   2,982,908
          
    Non-controlling interest (1)   (3,464,218)
    Goodwill (2)  $13,945,924 

     

    (1) Fair value of the noncontrolling interest based on NCI’s 49% interest in the net assets acquired.
    (2) Goodwill is calculated as Total Consideration paid less the net assets acquired.

     

    19
     

     

    NOTE 5 — FIXED ASSETS, SOFTWARE DEVELOPMENT COSTS, AND INTANGIBLE ASSET

     

    Fixed assets consisted of the following as of March 31, 2025 and December 31, 2024:

     SCHEDULE OF FIXED ASSETS

       March 31,   December 31, 
       2025   2024 
    At Cost:          
    Equipment  $125,546   $125,546 
    Furniture and fixtures   26,339    26,339 
    Leasehold improvements   62,721    62,721 
    Capital lease   23,004    23,004 
    Software   13,500    13,500 
    Property plant and equipment, gross   251,110    251,110 
               
    Less: Accumulated depreciation          
    Equipment   123,187    121,869 
    Furniture and fixtures   19,510    19,396 
    Leasehold improvements   62,721    62,721 
    Capital lease   19,897    19,897 
    Software   7,183    6,906 
    Less: Accumulated depreciation   232,498    230,789 
               
     Property plant and equipment, net   $18,612   $20,321 

     

    During the three months ended March 31, 2025 and 2024, the Company recorded depreciation expenses in cost of revenue of $1,709 and $733, respectively, and selling, general and administrative expenses of 1,709 and $1,464, respectively.

     

    Software development costs consisted of the following as of March 31, 2025 and December 31, 2024:

     

    SCHEDULE OF SOFTWARE DEVELOPMENT COSTS

       March 31,   December 31, 
       2025   2024 
    At Cost:          
    Software development cost   4,221,981    4,151,981 

     

    During the three months ended March 31, 2025 and 2024, the Company incurred software development costs of $70,000 and $105,000, respectively.

     

    20
     

     

    In 2024, the Company reclassed software development costs from fixed asset to software development costs. The Company continuing incurs costs to develop new modules, functionalities, and integrations on previous purchased SaaS platform in order to develop a new product with differentiated offering. As of March 31, 2025, the SaaS platform is still undergoing development stage and not ready for external sales. No amortization has been recorded during the three months ended March 31, 2025 and 2024.

     

    In 2024, the Company reclassed a part of software from fixed asset to software development costs.

     

    Intangible assets consisted of the following as of March 31, 2025 and December 31, 2024:

     SCHEDULE OF INTANGIBLE ASSETS

       March 31,   December 31, 
       2025   2024 
    At Cost:          
    Contractual relationship  $66,361   $66,361 
    Implementation   28,099    28,099 
    Software   100,000    100,000 
    Intangible assets, gross   194,460    194,460 
    Less: Accumulated amortization          
    Contractual relationship   66,361    66,361 
    Implementation   28,099    28,099 
    Software   83,333    75,000 
    Accumulated amortization   177,793    169,460 
               
    Intangible assets, net  $16,667   $25,000 

     

    During the three months ended March 31, 2025 and 2024, the Company recorded amortization expenses in selling, general and administrative expenses of $8,333 and $0, respectively.

     

    NOTE 6 — GOODWILL

     

    Acquisition of Axxum Technologies, LLC.

     

    On November 22, 2017, the Company entered into a share transfer agreement with Axxum and the two prior members of Axxum to purchase 100% of the members’ equity interest in the Company in exchange for $6,500,000 in cash and $500,000 in two subordinated convertible promissory notes for $250,000 each, payable to the two members of Axxum. Accordingly, Axxum became a wholly-owned subsidiary of the Company. The Company assessed the carrying value of Axxum’s assets and liabilities at the date of acquisition and determined that the carrying value of those accounts approximated fair value; the difference between the purchase price paid for the acquisition of Axxum and the net asset value derived from the assets and liabilities of Axxum at the date of acquisition has been recognized as goodwill. Accordingly, the purchase costs of $6,500,000 in cash, $500,000 in promissory notes, and $140,005 in capitalized transaction costs, less $573,150 in adjustment in working capital that is recoverable from sellers resulted in a total purchase cost of $6,566,855; the net asset value of Axxum at the date of acquisition was $1,413,589; accordingly, the Company recognized $5,153,266 in goodwill related to the acquisition of Axxum.

     

    21
     

     

    Acquisition of Cloudburst Security, LLC.

     

    On April 3, 2019, the Company entered into a membership interest purchase agreement with Cloudburst Security, LLC, a Virginia limited liability company, and its two equity holders to purchase 100% of the issued and outstanding units in exchange for $500,000 in cash; $540,000 for a promissory note to one equity holder and $360,000 to the other; and 111,628 and 74,420 shares of the Company’s common stock to the two equity holders, respectively, on a post-split basis. Accordingly, Cloudburst became a wholly-owned subsidiary of the Company. The Company assessed the carrying value of Cloudburst’s assets and liabilities at the date of acquisition and determined that the carrying value of those accounts approximated fair value; the difference between the purchase price paid for the acquisition of Cloudburst and the net asset value derived from the assets and liabilities of Cloudburst at the date of acquisition has been recognized as goodwill. The purchase costs of $500,000 in cash, $900,000 in promissory notes, $300,000 in 186,048 shares of the Company’s common stock, $1,400,000 in contingent earnout, $62,305 in capitalized transaction costs, resulted in a total purchase cost of $3,162,305; the net asset value of Cloudburst at the date of acquisition was $323,267; accordingly, the Company recognized $2,839,038 in goodwill related to the acquisition of Cloudburst. On April 20, 2022, the holders of the (i) $900,000 promissory notes and (ii) 186,048 shares of the Company’s common stock tendered them to the Company for cancellation.

     

    Relevant factors to the Company’s assessment of the carrying value of goodwill for both business combinations in accordance to the fair value hierarchy under the category of level 3 are as follows: estimation of the growth rate of future incoming and outgoing cash flows, certain elements that comprise the appropriate weighted average cost of capital, such as the equity of potential market participants for comparability analysis, and the Company’s sensitivity to outside factors that would lead to variation in the aforementioned cash flows and weighted average cost of capital.

     

    The Company’s management reviewed the performance of Cloudburst and its manager during the year ended December 31, 2020 and determined that Cloudburst had not met the performance targets set forth at the time of acquisition; as a result, the manager of Cloudburst was dismissed. Management of the Company performed a quantitative analysis of the carrying value of the subsidiary and its related goodwill by preparing a future discounted cash flow analysis, which included variables such as expectations on future cash flows, calculation of the cost of capital, and the probability of capturing certain contracts under the framework of Cloudburst being a federal government approved service provider, and determined that the fair value as of December 31, 2020 was lower than the carrying value that was previously established at the point of acquisition; accordingly, during the year ended December 31, 2020, the Company determined that the contingent earnout should be de-recognized, and written off in its entirety in the amount of $1,400,000 to the Company’s result of operations, and, as a result of the above assessment, the Company recognized an impairment of goodwill in the amount of $1,400,000 that was also recognized to the Company’s results of operations. The Company’s ending goodwill related to the acquisition of Cloudburst after recognizing impairment was $1,439,038.

     

    Acquisition of SLG Innovation Inc.

     

    The Company initiated discussions to acquire SLG in late 2020, advancing an initial non-refundable deposit of $1.4 million for loans, capitalized transaction costs, and accounts receivable. By December 31, 2024, this deposit had increased to $2 million. On May 13, 2021, the Company entered into an agreement to acquire substantially all of SLG’s assets and certain liabilities, later amended to focus on specific sales contracts. A unidirectional letter of intent (LOI) was executed on April 29, 2023, binding SLG to the transaction while allowing the Company the option to proceed. The LOI contemplated a structure involving the $2 million receivable, $2.1 million in SLG payables to RCR Technology Corporation, and 996,355 shares of the Company’s capital stock.

     

    On March 31, 2025, the Company finalized an agreement to acquire 51% equity interest in SLG. The total purchase consideration included the $2 million prepaid deposit, 508,141 shares of common stock (par value $0.0001), 51 shares of Series E Preferred Stock (face value $10,000 each, conversion price $1.00) and $10,814,147 of accounts receivable in Cycurion owing from SLG. Additionally, the Company issued 500,000 common shares to assume SLG’s share-based payment obligations.

     

    22
     

     

    The acquisition was accounted for as a business combination under ASC 805. As of the acquisition date, the fair value of assets acquired totaled $3,101,564, including $34,983 in cash and $3,066,581 in accounts receivable. Liabilities assumed amounted to $10,171,396, including accounts payable, accrued liabilities, payroll liabilities, and loans. After recognizing a non-controlling interest of $3,464,218, the net assets acquired were negative $7,069,832 million. The total consideration transferred exceeded the net assets acquired, resulting in the recognition of goodwill amounting to $13,945,924. This goodwill reflects the strategic value of SLG’s operations, expected synergies, and future growth potential.

     SCHEDULE OF GOODWILL

      2025   2024 
    Goodwill        
    Axxum   $5,153,266   $5,153,266 
    Cloudburst   1,439,038    1,439,038 
    SLG   13,945,924    - 
    Total Goodwill  $20,538,228   $6,592,304 

     

    NOTE 7 — BANK LOANS

     

    Bank loan-revolving credit line

     

    On November 22, 2017, Axxum procured from Main Street Bank a revolving line of credit with a maximum of up to $1,000,000, subject to certain restrictions based on available collateral pledged to the bank in the form of accounts and trade receivables owed by the Company’s customers. This revolving credit line is available for one year, at which point it may be renewed by Axxum. Axxum incurred origination and closing costs for this line of credit in the amount of $10,000, which Axxum has recognized a prepaid expense that will amortize over one year as interest expense. The stated rate of interest of the revolving line of credit is the prime rate plus 100 basis points, which, at the time of the loan, was 4.50%.

     

    On April 18, 2019, Axxum, Cloudburst, and the Company collectively renewed the revolving line of credit with a maximum aggregate principal sum of $2,000,000 with Main Street Bank. The stated rate of interest of the revolving line of credit increased to 5.75% at the time of the renewal.

     

    On June 29, 2020 and again on June 30, 2021, the Company amended the revolving line of credit with an extension of the maturity date to March 31, 2024. The stated rate of interest of the revolving line of credit decreased to 5.25% at the time of the first amendment and an additional 5% default interest on the second amendment.

     

    As of March 31, 2025, the stated rate of interest of the revolving line of credit was 8.50%. The outstanding balance of the line of credit was $3,239,767 and $3,249,067, respectively, as of March 31, 2025 and December 31, 2024.

     

    Bank term loan Concurrent with Axxum’s procurement of the above-mentioned revolving credit line, Axxum also procured a term loan from Main Street Bank in the amount of $5,250,000 with an expiration of December 31, 2024. The loan is subject to a monthly repayment of principal in the amount of $109,375. The loan carries a stated adjustable interest rate of the prime rate plus 200 basis points, which, at the time of the loan, was 5.50%. Axxum incurred closing and origination costs totaling $211,729. The imputed interest rate after giving effect for the closing and origination costs was 7.82%.

     

    23
     

     

    Axxum is subject to the following affirmative loan covenants: (i) on or after December 31, 2017 but prior to June 30, 2018, minimum tangible net worth (net liability) of $2,250,000; on or after June 30, 2018 but prior to June 30, 2019, minimum tangible net worth (net liability) of $1,250,000; on or after June 30, 2019 but prior to December 31, 2019, minimum tangible net worth (net liability) of $950,000; on or after December 31, 2019 but prior to June 30, 2020, minimum tangible net worth (net asset) of $1750,000; on or after June 30, 2020 but prior to December 31, 2020, minimum tangible net worth (net asset) of $2,500,000; on or after December 31, 2020 but prior to June 30, 2021, minimum tangible net worth (net asset) of $3,000,000; on or after June 30, 2021 but prior to December 31, 2021, minimum tangible net worth (net asset) of $3,500,000; on or after December 31, 2021, minimum tangible net worth (net asset) of $5,000,000, (ii) interest coverage ratios must be greater than 1.25-to-1, measured on quarterly basis, using a rolling four-quarter basis, beginning with the fiscal quarter ending December 31, 2017, (iii) the Company and Axxum must achieve minimum consolidated earnings before tax interest, tax, depreciation and amortization of (“EBITDA”) greater than $300,000 per quarter, and (iv) annual capital expenditures must be less than $50,000. Management conferred with the bank regarding the covenants and determined that the Company was in compliance after giving effect to clarification in the definitions and formulas set forth by the bank in regard to the calculation of the above covenants.

     

    On April 18, 2019, Axxum, Cloudburst, and the Company collectively amended the Loan and Security Agreement, including the addition of Cloudburst as a borrower. The stated interest rate increased to 6.75% and the loan covenants remained the same.

     

    On June 29, 2020, the Company amended and restated the Loan and Security Agreement by extending the maturity date to March 22, 2024 with a monthly repayment of principal in the amount of $62,500 on or after June 22, 2020. The stated interest rate decreased to 6.25%.

     

    The loan covenants were replaced as follows: (i) on or after June 30, 2020 but prior to December 31, 2020, minimum tangible net worth (net liability) of $2,750,000; on or after December 31, 2020 but prior to June 30, 2021, minimum tangible net worth (net liability) of $2,250,000; on or after June 30, 2021 but prior to December 31, 2021, minimum tangible net worth (net liability) of $1,750,000; on or after December 31, 2021, but prior to June 30, 2022, minimum tangible net worth (net liability) of $1,250,000; on or after June 30, 2022 but prior to December 31, 2022, minimum tangible net worth (net asset) of $500,000; on or after December 31, 2022, but prior to June 30, 2023, minimum tangible net worth (net asset) of $1,250,000; on or after June 30, 2023 but prior to December 31, 2023, minimum tangible net worth (net asset) of $2,000,000; on or after December 31, 2023, minimum tangible net worth (net asset) of $2,500,000, (ii) interest coverage ratios must be greater than 1.20-to-1, measured on quarterly basis, using a rolling four-quarter basis, beginning with the fiscal quarter ending June 30, 2020 (iii) the Company must achieve minimum consolidated EBITDA greater than $300,000 per quarter, and (iv) annual capital expenditures must be less than $50,000.

     

    As of March 31, 2025, the stated rate of interest of the loan was 9.5%.

     

    The Company has categorized balances due within one operating period as current and those payments due after one operating period as long-term. As of March 31, 2025 and December 31, 2024, the Company recorded bank loan-current portion of $770,078, net of debt discount of $0 and $774,095, net of debt discount of $1,097 and bank loan-long term portion of $0, net of debt discount of $0 and $0, and net of debt discount of $0 and, respectively.

     

    Pledge agreement

     

    Concurrent with Axxum’s procurement of the above-mentioned revolving credit line and loan, Axxum entered into a Pledge Agreement. The following pledges of collateral and credit enhancement were made by Axxum and the Company as the sole member of Axxum: (i) the Company equity ownership in Axxum and (ii) all of Axxum’s assets, such as accounts, instruments, equipment, fixtures, deposit accounts, letter of credit rights, and any other assets. All future debt is subordinated to the bank term loan until the term loan is repaid in full. Personal guarantees have also been made by Emmit McHenry, Kurt McHenry, and Alvin McCoy III, as officers and stockholders of the Company in support of the term loan.

     

    24
     

     

    On April 18, 2019, Axxum, Cloudburst, and the Company collectively amended the Pledge Agreement, including the addition of Cloudburst as a pledgor. The following pledges of collateral and credit enhancement were made by Axxum, Cloudburst, and the Company: (i) all of the equity of Axxum, Cloudburst and each other subsidiary of the Company then owned or hereafter acquired by the Company and (ii) all rights to which the owner of the pledged equity then or may thereafter become entitled by virtue of owning such pledged equity and being a member of Axxum, Cloudburst, and each other subsidiary of the Company.

     

    During the three months ended March 31, 2025 and 2024, the Company record amortization of discount of $1,097 and $0, respectively.

     

    NOTE 8 — LOANS PAYABLE

     

    The following table summarizes the components of the Company’s loans payable and advances as of March 31, 2025 and December 31, 2024:

     SCHEDULE OF LOAN PAYABLE AND ADVANCES

       March 31,   December 31, 
       2025   2024 
             
    Loan payable  $405,314    405,314 
    Loan payable-SLG   264,379    - 
    EIDL Cycurion Loan   150,000    150,000 
    EIDL SLG Loan   157,220    - 
    Private Loan payable   203,623    - 
    Total face value   1,180,536    555,314 
    Unamortized discount   -    - 
    Total loans payable   1,180,536    555,314 
    Current portion of loans payable and advances   885,240    408,516 
    Long-term portion of loans payable and advances  $295,296   $146,798 

     

    Loan payable

     

    On March 20, 2023, the Company entered into a receivable purchase agreement (the “RPA Loan”) for case received of $339,500, with a specified interest rate of 8.00%, due January 20, 2024. The RPA Loan requires weekly payments of $15,302, until $489,650 is repaid. As of March 31, 2025 and December 31, 2024, the Company recognized a balance owing of $405,314, respectively, and the loan is in default.

     

    EIDL Cycurion Loan

     

    On July 16, 2020, the Company executed the standard loan documents required for securing loans (the “EIDL Loan - Cycurion”) offered by the U.S. Small Business Administration (the “SBA”) under its Economic Injury Disaster Loan (“EIDL”) assistance program in light of the impact of the COVID-19 pandemic on the Company’s business. The principal amount of the EIDL Cycurion Loan is $150,000, with proceeds to be used for working capital purposes. Interest accrues at the rate of 3.75% per annum and will accrue from the date of the EIDL Cycurion Loan. Installment payments, including principal and interest, are due monthly beginning July 16, 2021 (twelve months from the date of the EIDL Cycurion Loan) in the amount of $731. The balance of principal and interest is payable 30 years from the date of the EIDL Cycurion Loan. The Company recorded note payable as $3,202 of loan payable under current liability as of March 31, 2025 and $295,296 and $146,798 of long-term loan payable, respectively, as of March 31, 2025 and December 31, 2024.

     

    25
     

     

    EIDL SLG Loan

     

    On September 30, 2020, the Company executed the standard loan documents required for securing loans (the “EIDL SLG Loan”) offered by the SBA under its EIDL assistance program in light of the impact of the COVID-19 pandemic on the Company’s business. The principal amount of the EIDL SLG Loan is $150,000, with the proceeds to be used for working capital purposes. Interest accrues at the rate of 3.75% per annum and will accrue from the date of the EIDL SLG Loan. Installment payments, including principal and interest, are due monthly beginning January 1, 2023 in the amount of $731. The balance of principal and interest is payable 30 years from the date of the EIDL SLG Loan (June 30, 2050). As of March 31, 2025, the balance of the EIDLSLG Loan including interest is $157,220.

     

    Loan Payable-SLG

     

    In 2022 and 2023, the Company entered into non-recourse agreements with a lender to sell future receipts. Under the agreement, the Company was required to make daily payments. The terms were renegotiated to monthly payments in 2023. As of March 31, 2025, the balance on the loan is $264,379 and it is currently in default.

     

    Private Loan payable

     

    In 2017, the Company entered into a loan agreement with a third party to provide up to $500,000. The funds can be requested on an as-needed basis based on a 10-30% interest rate. As of March 31, 2025, the balance on the loan is $203,623 and is currently in default.

     

    NOTE 9 — PROMISSORY NOTES

     

    The following table summarizes the components of the Company’s promissory notes of March 31, 2025 and December 31, 2024:

     SCHEDULE OF PROMISSORY NOTES

       March 31,   December 31,   Stated   Maturity 
       2025   2024   interest   (Calendar year) 
                     
    Note issued in 2017  $250,000   $250,000    4%   2020 
    Notes issued prior to 2021   700,000    700,000    24%   2021 - 2022 
    Notes issued in 2023   1,067,611    1,067,611    12 - 24%   2023 
    Notes issued in 2024   517,425    480,758    10 - 24%   2025 
    Notes issued in 2025   670,558    -    10 - 35%   2025 - 2026 
    Total face value   3,205,594    2,498,369           
    Unamortized discount and issuance costs   (67,441)   (11,380)          
    Total notes payable  $3,138,153   $2,486,989           

     

    During the three months ended March 31, 2025, the Company issued promissory notes in the amount of $690,558, for $513,200 in proceeds to unaffiliated investors and for $100,000 to be released from the binding term sheet with a future equity line to an unaffiliated investor, and the Company repaid a promissory note of $20,000.

     

    26
     

     

    During the three months ended March 31, 2025 and 2024, the Company record amortization of debt discount of $56,061 and $0, respectively.

     

    Subordinated Convertible Promissory notes payable

     

    On March 22, 2022, the Company issued subordinated convertible promissory notes with principal value of $526,315 to six investors. While subordinate to bank lender the notes are secured by The Company’s assets. The Company issued to an independent director a $236,842 subordinated convertible note. The Company issued to an otherwise unaffiliated investors of subordinated convertible notes in principal amounts of $52,631 to three investors, $105,263 to a fifth investor and $26,315 to a sixth investor. The notes carry annual interest rate of 8% that commenced upon funding date through the date of repayment.

     

    On November 22, 2022, the Company issued to three otherwise unaffiliated investors $2,777,778 promissory notes, 394,011 common shares and 984,557 warrants for $2,500,000 in gross proceeds.

     

    The Company entered into the Merger Agreement with Western and Merger Sub, on November 21, 2022, as amended. As a result of the Business Combination, Cycurion raised $3,333,335 of debt capital on November 21, 2022, from nine (9) unaffiliated investors who were issued for convertibles notes, warrants and shares of common stock. The convertible notes had a maturity date of November 21, 2023, and an interest rate of 8%. They were also issued to convert to equity upon completion of the Business Combination between Cycurion and Western.

     

    During the three months ended March 31, 2025, the Company issued preferred stocks and warrants in exchange of the outstanding convertible promissory notes which had an aggregate principal amount of $3,333,335 and accrued interest of $299,259. As a part of this conversion, the Company issued 6,666,667 shares of Series D Convertible Preferred Stock and 7,272,728 Series D warrants to seven (7) unaffiliated noteholders. As a result, the Company recorded gain on settlement of debt of $299,259.

     

    As of March 31, 2025 and December 31, 2024, the Company had outstanding convertible promissory notes of $0 $3,333,335 respectively.

     

    NOTE 10 – CONVERTIBLE NOTES

     

    The following table summarizes the components of the Company’s convertible notes of March 31, 2025 and December 31, 2024:

     SCHEDULE OF CONVERTIBLE NOTES

       March 31,   December 31,   Stated   Maturity 
       2025   2024   interest   (Calendar year) 
                     
    Notes issued in 2025  $440,217    -    18%   2026 
    Total face value   440,217    -           
    Unamortized discount and issuance costs   (49,241)   -           
    Total notes payable  $390,976   $-           

     

    During the three months ended March 31, 2025, the Company issued convertible notes in the amount of $440,217 for $386,500 in proceeds to three unaffiliated investors. The notes have a term of one (1) year from issuance and carry annual interest rate of 18% that commenced upon funding date through the date of repayment. The notes have a conversion price of $1.75 per share.

     

    27
     

     

    During the three months ended March 31, 2025 and 2024, the Company record amortization of debt discount of $4,476 and $0, respectively.

     

    NOTE 11 – FACTORING LIABILITY

     

    On July 12, 2022, the Company entered into agreement with a lender Factor A, whereby the Factor A would loan proceeds against certain accounts receivable up to 90% of the total value of the invoice, which is paid to the Company in the form of a cash advance. A factoring cost of 1.5% is applied for days 1-30 after the loan is funded, and an additional 0.5% fee charge is applied for each additional 10 days period thereafter. The maximum facility is $3 million.

     

    Accordingly, pursuant to ASC 860-20-55-24, the Company recognized a factoring liability to the lenders until the accounts receivable are collected. As of March 31, 2025, the factoring liability was $2,176,922.

     

    NOTE 12 — SERIES A CONVERTIBLE PREFERRED STOCK

     

    As of December 31, 2024, the Company had designated 500,000 shares of Series A Convertible Preferred Stock with a par value of $0.001 per share. The Series A had voting rights on an as-if-converted to common stock basis. The holders were entitled to a 10% dividend and convert at any time into shares of common stock at a ratio of 1 to 25.6938 shares of common stock, subject to adjustment.

     

    As a part of the Business Combination with Western, the Company issued 106,816 shares of Series A Convertible Preferred Stock, par value $0.0001 per share (“Class A Convertible Preferred Stock”), in connection with the conversion and settlement of previously outstanding securities mentioned above. Refer Note 13 for the characteristic of newly issued Series A Convertible Preferred stock.

     

    NOTE 13 — EQUITY

     

    Preferred Stock

     

    The Company has authorized 20,000,000 shares of preferred stock, par value of $0.0001 per share, issuable from time to time in one or more series.

     

    Mezzanine Equity

     

    As of March 31, 2025 and December 31, 2024, there are 0 and 173,879 shares of common stock subject to possible redemption, respectively.

     

    Stockholders’ Equity

     

    Series A Convertible Preferred Stock

     

    The Company has designated 110,000 shares of Series A Convertible Preferred Stock with a stated value of $1.45 per share.

     

    28
     

     

    Voting Rights: The holders of our Cycurion’s Series A Stock have voting rights on an as-if-converted-to-Common-Stock basis, and as required by law (including without limitation, the GCL) and as expressly provided in this Certificate of Designation. As long as any shares of Preferred Stock are outstanding, the Corporation shall not, without the affirmative vote of the Holders of a majority of the then-outstanding shares of the Preferred Stock, (a) alter or change adversely the powers, preferences, or rights given to the Preferred Stock or alter or amend this Certificate of Designation, (b) amend its certificate of incorporation or other charter documents in any manner that adversely affects any rights of the Holders, (c) increase the number of authorized shares of Preferred Stock, or (d) enter into any agreement with respect to any of the foregoing.

     

    Dividend Rights: Holders of shares of Cycurion’s Series A Convertible Preferred Stock shall entitled to receive, dividends on shares of Preferred Stock at the rate of twelve percent (12%) per annum of the per-share Stated Value ($1.45 per share). The dividends shall be paid payable quarterly in arrears in shares of common stock, calculated for each dividend payment on an as-if-converted-to-Common-Stock basis. No other dividends shall be paid on shares of Preferred Stock.

     

    Conversion Rights: Shares of Cycurion’s Series A Convertible Preferred Stock shall be convertible, at any time and from time to time at the option of the holder thereof, into shares of common stock (subject to certain 4.99% or 9.99% blocker limitations) at the conversion ratio of one share of Series A Convertible Preferred Stock-for-one share of common stock, subject to adjustment.

     

    Liquidation Preference: Holders of shares of Cycurion’s Series A Convertible Preferred Stock, upon any liquidation, dissolution, or winding-up of Cycurion, whether voluntary or involuntary, shall be entitled to receive out of the assets, whether capital or surplus, of Cycurion an amount equal to the Stated Value, plus any accrued and unpaid dividends thereon, for each share of Series A Convertible Preferred Stock before any distribution or payment shall be made to the holders of common stock, and, if the assets of Cycurion shall be insufficient to pay in full such amounts, then the entire assets to be distributed to the holders of shares of Series A Convertible Preferred Stock shall be ratably distributed among them in accordance with the respective amounts that would have been payable on such shares if all amounts payable thereon had been paid in full.

     

    Protective Provisions: As long as any shares of Series A Convertible Preferred Stock are outstanding, Cycurion shall not, without the affirmative vote of the holders of a majority of the then-outstanding shares of Series A Convertible Preferred Stock, (a) alter or change adversely the powers, preferences, or rights given to the holders of Series A Convertible Preferred Stock or alter or amend the Certificate of Designation of Preferences, Rights and Limitations for Cycurion’s Series A Convertible Preferred Stock, (b) amend its certificate of incorporation or other charter documents in any manner that adversely affects any rights of the holders of shares of Series A Convertible Preferred Stock, (c) increase the number of authorized shares of Series A Convertible Preferred Stock, or (d) enter into any agreement with respect to any of the foregoing.

     

    As part of the acquisition of Western during the three months ended March 31 2025, the Company issued to unaffiliated investors a total of 106,816 preferred shares.

     

    As of March 31, 2025 and December 31, 2024, there were 106,816 and 0 of Series A Convertible Preferred Stock issued and outstanding, respectively.

     

    Series B Convertible Preferred Stock

     

    The Company has designated 3,000 shares of Series B Convertible Preferred Stock with a stated value of $1.00 per share.

     

    29
     

     

    Voting Rights: Holders of shares of Cycurion’s Series B Convertible Preferred Stock shall not have any voting rights except as required by law (including without limitation, the DGCL) and as expressly provided in the Certificate of Designation of Preferences, Rights and Limitations for Cycurion’s Series B Convertible Preferred Stock.

     

    Dividend Rights: Holders of shares of Cycurion’s Series B Convertible Preferred Stock shall be entitled to receive, and Cycurion shall pay, dividends on shares of Series B Convertible Preferred Stock (on an as-if-converted-to-Common-Stock basis) to and in the same form as dividends actually paid on shares of common stock when, as, and if such dividends are paid on shares of common stock.

     

    Conversion Rights: Shares of Cycurion’s Series B Convertible Preferred Stock shall be convertible, at any time and from time to time at the option of the holder thereof, into shares of common stock (subject to certain 4.99% or 9.99% blocker limitations) at the conversion ratio of one share of Series B Convertible Preferred Stock-for-one share of common stock, subject to adjustment.

     

    Liquidation Preference: Holders of shares of Cycurion’s Series B Convertible Preferred Stock, upon any liquidation, dissolution, or winding-up of Cycurion, whether voluntary or involuntary, shall be entitled to receive out of the assets, whether capital or surplus, of Cycurion an amount equal to the Stated Value, plus any accrued and unpaid dividends thereon, for each share of Series B Convertible Preferred Stock before any distribution or payment shall be made to the holders of common stock, and, if the assets of Cycurion shall be insufficient to pay in full such amounts, then the entire assets to be distributed to the holders of shares of Series B Convertible Preferred Stock shall be ratably distributed among them in accordance with the respective amounts that would have been payable on such shares if all amounts payable thereon had been paid in full.

     

    Protective Provisions: As long as any shares of Series B Convertible Preferred Stock are outstanding, Cycurion shall not, without the affirmative vote of the holders of a majority of the then-outstanding shares of Series B Convertible Preferred Stock, (a) alter or change adversely the powers, preferences, or rights given to the holders of Series B Convertible Preferred Stock or alter or amend the Certificate of Designation of Preferences, Rights and Limitations for Cycurion’s Series B Convertible Preferred Stock, (b) amend its certificate of incorporation or other charter documents in any manner that adversely affects any rights of the holders of shares of Series B Convertible Preferred Stock, (c) increase the number of authorized shares of Series B Convertible Preferred Stock, or (d) enter into any agreement with respect to any of the foregoing.

     

    As part of the acquisition of Western, during the three months ended March 31 2025, the Company issued to unaffiliated investors a total of 3,000 preferred shares of series B Convertible Preferred Stock in exchange of existing 3,000 Series B Convertible Preferred Stock.

     

    During the three months ended as of March 31, 2025, a total of 2,999 Series B Convertible Preferred Stock were converted into 5,998,653 shares of common stock.

     

    As of March 31, 2025 and December 31, 2024, there were 1 and 3,000 shares of Series B Convertible Preferred Stock issued and outstanding, respectively.

     

    Series C Convertible Preferred Stock

     

    The Company has designated 5,000 shares of Series C Convertible Preferred Stock with a stated value of $82.46 per share.

     

    30
     

     

    Voting Rights: The holders of our Series C Stock have voting rights on an as-if-converted-to-Common-Stock basis, as required by law, and as expressly provided in its Certificate of Designation, as follows. As long as any shares of our Series C Stock are outstanding, we shall not, without the affirmative vote of the holders of a majority of the then-outstanding shares of our Series C Stock, (a) alter or change adversely the powers, preferences, or rights given to our Series C Stock or alter or amend its Certificate of Designation, (b) amend our Certificate of Incorporation or other charter documents in any manner that adversely affects any rights of the holders of our Series C Stock, (c) increase the number of authorized shares of our Series C Stock, or (d) enter into any agreement with respect to any of the foregoing.

     

    Dividend Rights: We shall pay dividends on our Series C Stock at the rate of 12% per annum of the per-share Stated Value ($82.46 per share). The dividends are payable quarterly in arrears not in cash, but in shares of our common stock, calculated for each dividend payment on an as-if-converted-to-Common-Stock basis. No other dividends are payable on shares of our Series C Stock.

     

    Conversion Rights: The shares of our Series C Stock may be converted into shares of our common stock at a ratio of approximately 613 shares of common stock for every one share of our Series C Stock, or an aggregate of 2,972,320 shares of our common stock, assuming full conversion. In connection with conversions, each holder of our Series C Stock is subject to a “beneficial ownership limitation” of 4.99% of the number of shares of our common stock outstanding immediately after giving effect to that conversion, which limitation may be increased by the holder to not more than 9.99% on 61 days’ advanced notice to us.

     

    Liquidation Preference: Our Series C Stock has a liquidation preference in an amount equal to its per-share Stated Value ($82.46 per share), plus any accrued and unpaid dividends thereon, for each share of our Series C Stock before we can make any distribution or payment to the holders of our common stock. If our assets are insufficient to pay in full such liquidation preference, then our entire assets are to be distributed to the holders of our Series C Stock, ratably distributed among them in accordance with the respective amounts that would be payable on such shares if all amounts payable thereon were paid in full.

     

    Protective Provisions: As long as any shares of Series C Convertible Preferred Stock are outstanding, Cycurion shall not, without the affirmative vote of the holders of a majority of the then-outstanding shares of Series C Convertible Preferred Stock, (a) alter or change adversely the powers, preferences, or rights given to the holders of Series C Convertible Preferred Stock or alter or amend the Certificate of Designation of Preferences, Rights and Limitations for Cycurion’s Series C Convertible Preferred Stock, (b) amend its certificate of incorporation or other charter documents in any manner that adversely affects any rights of the holders of shares of Series C Convertible Preferred Stock, (c) increase the number of authorized shares of Series C Convertible Preferred Stock, or (d) enter into any agreement with respect to any of the foregoing.

     

    As part of the acquisition of Western, during the three months ended March 31 2025, the Company issued a total of 4,851 preferred shares of series C Convertible Preferred Stock in exchange of existing 1,356,586 shares of Cycruion common stock and 406,969 Warrants.

     

    As of March 31, 2025 and December 31, 2024, there were 4,851 shares of Series C Convertible Preferred Stock issued and outstanding.

     

    Series D Convertible Preferred Stock

     

    The Company has designated 6,666,700 shares of Series B Convertible Preferred Stock with a stated value of $0.50 per share.

     

    31
     

     

    Voting Rights: Holders of shares of Cycurion’s Series D Convertible Preferred Stock shall not have any voting rights except as required by law (including without limitation, the DGCL) and as expressly provided in the Certificate of Designation of Preferences, Rights and Limitations for Cycurion’s Series D Convertible Preferred Stock.

     

    Dividend Rights: Holders of shares of Cycurion’s Series D Convertible Preferred Stock shall be entitled to receive, and Cycurion shall pay, dividends on shares of Series D Convertible Preferred Stock (on an as-if-converted-to-Common-Stock basis) to and in the same form as dividends actually paid on shares of common stock when, as, and if such dividends are paid on shares of common stock.

     

    Conversion Rights: Shares of Cycurion’s Series D Convertible Preferred Stock shall be convertible, at any time and from time to time at the option of the holder thereof, into shares of common stock (subject to certain 4.99% or 9.99% blocker limitations) at the conversion ratio of one share of Series B Convertible Preferred Stock-for-one share of common stock, subject to adjustment.

     

    Liquidation Preference: Holders of shares of Cycurion’s Series D Convertible Preferred Stock, upon any liquidation, dissolution, or winding-up of Cycurion, whether voluntary or involuntary, shall be entitled to receive out of the assets, whether capital or surplus, of Cycurion an amount equal to the Stated Value, plus any accrued and unpaid dividends thereon, for each share of Series D Convertible Preferred Stock before any distribution or payment shall be made to the holders of common stock, and, if the assets of Cycurion shall be insufficient to pay in full such amounts, then the entire assets to be distributed to the holders of shares of Series D Convertible Preferred Stock shall be ratably distributed among them in accordance with the respective amounts that would have been payable on such shares if all amounts payable thereon had been paid in full.

     

    Protective Provisions: As long as any shares of Series D Convertible Preferred Stock are outstanding, Cycurion shall not, without the affirmative vote of the holders of a majority of the then-outstanding shares of Series D Convertible Preferred Stock, (a) alter or change adversely the powers, preferences, or rights given to the holders of Series D Convertible Preferred Stock or alter or amend the Certificate of Designation of Preferences, Rights and Limitations for Cycurion’s Series D Convertible Preferred Stock, (b) amend its certificate of incorporation or other charter documents in any manner that adversely affects any rights of the holders of shares of Series D Convertible Preferred Stock, (c) increase the number of authorized shares of Series D Convertible Preferred Stock, or (d) enter into any agreement with respect to any of the foregoing.

     

    As part of the acquisition of Western, during the three months ended March 31 2025, the Company issued to unaffiliated investors a total of 6,666,666 preferred shares of series D Convertible Preferred Stock.

     

    During the three months ended as of March 31, 2025, a total of 6,516,666 Series D Convertible Preferred Stock were converted into 6,516,666 shares of common stock.

     

    As of March 31, 2025 and December 31, 2024, there were 150,000 and 0 shares of Series D Convertible Preferred Stock issued and outstanding, respectively.

     

    Series E Convertible Preferred Stock

     

    The Company has designated 100 shares of Series E Convertible Preferred Stock with a stated value of $ 10,000 per share.

     

    32
     

     

    Voting Rights: Holders of shares of Cycurion’s Series E Convertible Preferred Stock shall not have any voting rights except as required by law (including without limitation, the DGCL) and as expressly provided in the Certificate of Designation of Preferences, Rights and Limitations for Cycurion’s Series B Convertible Preferred Stock.

     

    Dividend Rights: Holders of shares of Cycurion’s Series E Convertible Preferred Stock shall be entitled to receive, and Cycurion shall pay, dividends on shares of Series E Convertible Preferred Stock (on an as-if-converted-to-Common-Stock basis) to and in the same form as dividends actually paid on shares of common stock when, as, and if such dividends are paid on shares of common stock.

     

    Conversion Rights: Shares of Cycurion’s Series E Convertible Preferred Stock shall be convertible, at any time and from time to time at the option of the holder thereof, into shares of common stock (subject to certain 4.99% or 9.99% blocker limitations) at the conversion ratio of one share of Series E Convertible Preferred Stock-for-one share of common stock, subject to adjustment.

     

    Liquidation Preference: Holders of shares of Cycurion’s Series E Convertible Preferred Stock, upon any liquidation, dissolution, or winding-up of Cycurion, whether voluntary or involuntary, shall be entitled to receive out of the assets, whether capital or surplus, of Cycurion an amount equal to the Stated Value, plus any accrued and unpaid dividends thereon, for each share of Series E Convertible Preferred Stock before any distribution or payment shall be made to the holders of common stock, and, if the assets of Cycurion shall be insufficient to pay in full such amounts, then the entire assets to be distributed to the holders of shares of Series E Convertible Preferred Stock shall be ratably distributed among them in accordance with the respective amounts that would have been payable on such shares if all amounts payable thereon had been paid in full.

     

    Protective Provisions: As long as any shares of Series E Convertible Preferred Stock are outstanding, Cycurion shall not, without the affirmative vote of the holders of a majority of the then-outstanding shares of Series E Convertible Preferred Stock, (a) alter or change adversely the powers, preferences, or rights given to the holders of Series E Convertible Preferred Stock or alter or amend the Certificate of Designation of Preferences, Rights and Limitations for Cycurion’s Series E Convertible Preferred Stock, (b) amend its certificate of incorporation or other charter documents in any manner that adversely affects any rights of the holders of shares of Series E Convertible Preferred Stock, (c) increase the number of authorized shares of Series E Convertible Preferred Stock, or (d) enter into any agreement with respect to any of the foregoing.

     

    As part of the acquisition of SLG Innovation, during the three months ended March 31 2025, the Company issued to the majority shareholder a total of 51 preferred shares of series E Convertible Preferred Stock as consideration for the transaction.

     

    Common Stock

     

    The Company has authorized 100,000,000 shares of common stock, par value of $0.0001 per share. Each share of common stock entitles the holder to one vote, in person or proxy, on any matter on which an action of the stockholders of the Company is sought.

     

      ● 12,515,619 shares for conversion of series B and D convertible preferred stock.
      ● 7,044,917 shares for exercise of other warrant, Warrant A, B and D for $3,309,921
      ● 750,000 shares valued at $9,000,000 for business acquisition costs
      ● 78,803 shares valued at $945,628 for a settlement of debt of $788,803, as a result, the Company recorded loss on settlement of debt of $157,606

     

    33
     

     

      ● 500,000 shares valued at $250,000 for an employment agreement
      ● 508,141 shares valued at $764,020 for an acquisition of SLG
      ● 78,983 shares for a release of common stock subject to redemption

     

    As of March 31, 2025 and December 31, 2024, there were 32,068,770 and 10,592,607 shares of common stock issued and outstanding, respectively. The 32,068,770 shares of common stock include 624,864 shares of common stock to be issued to SLG and under certain equity plans.

     

    Warrants

     

    Public Warrants

     

    As of March 31, 2025 and December 31, 2024, there were 11,500,000 public warrants (“Public Warrants”) outstanding. The Company accounts for the Public Warrants as equity instruments. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the initial public offering. No warrants will be exercisable for cash unless the Company has an effective and current registration statement covering the shares of common stock issuable upon exercise of the warrants and a current prospectus relating to such shares of common stock. Notwithstanding the foregoing, if a registration statement covering the shares of common stock issuable upon exercise of the Public Warrants is not effective within a specified period following the consummation of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to the exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption is available. If neither that exemption nor another exemption is available, holders will not be able to exercise their warrants on a cashless basis.

     

    The Public Warrants will expire on February 14, 2030, five years after the completion of the Business Combination with Cycurion or earlier upon redemption or liquidation.

     

    Once the Public Warrants become exercisable, the Company may redeem the Public Warrants:

     

    ● in whole and not in part;
    ● at a price of $0.01 per Public Warrant;
    ● upon not less than 30 days’ prior written notice of redemption;
    ● if, and only if, the reported last sale price of the shares of common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations), for any 20 trading days within a 30 trading day period commencing at any time after the Public Warrants become exercisable and ending on the third business day prior to the notice of redemption to warrant holders; and
    ● if, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying the Public Warrants.

     

    If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement.

     

    The exercise price and number of shares of common stock issuable on exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a stock dividend, extraordinary dividend or recapitalization, reorganization, merger, or consolidation. However, the warrants will not be adjusted for issuances of shares of common stock at a price below their respective exercise prices. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of Public Warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expire and become worthless.

     

    34
     

     

    In addition, if (a) the Company issues additional shares of common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share of common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors, and in the case of any such issuance to the initial stockholders or their affiliates, without taking into account any Founder Shares held by them prior to such issuance), (b) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (c) the volume weighted average trading price of the Company’s common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the Public Warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of (i) the Market Value or (ii) the price at which the Company issues the additional shares of common stock or equity-linked securities.

     

    Private Placement Warrants

     

    As of March 31, 2025 and December 31, 2024, there were 376,000 private placement warrants (“Private Placement Warrants”) outstanding. The Company accounts for the Private Placement Warrants as equity instruments. The Private Placement Warrants sold in the private placement are identical to the Public Warrants underlying the Units sold in the IPO, except that such warrants, and the shares of common stock issuable upon the exercise of such warrants, will not be transferable, assignable, or salable until after February 14, 2025, the date of completion of a Business Combination, subject to certain limited exceptions.

     

    Series A Warrants

     

    On November 17, 2017, the Company had issued 1,333,336 Series A warrants at exercise price of $0.45 with expiry on November 22, 2025. As part of the acquisition of Western, during the three months ended March 31 2025, the Company issued to unaffiliated investors a total of 680,875 series A warrants in exchange of existing 1,333,336 series A warrants having expiry on February 19, 2029 and exercise price of $0.319707

     

    Series B Warrants

     

    On August 1, 2023, the Company had issued 4,000,000 Series B warrants with an exercise price of $0.50. with expiry on August 1, 2028.

     

    On April 12, 2024, the Company issued 2,000,000 Series B warrants with an exercise price of $0.50. The warrants will expire on April 12, 2029.

     

    As part of the acquisition of Western, during the three months ended March 31 2025, the Company issued to unaffiliated investors a total of 6,000,000 series B warrants in exchange of existing 6,000,000 series B warrants having expiry on February 19, 2030 and exercise price of $0.50.

     

    Series D Warrants

     

    On March 22, 2022, the Company had issued 196,911 warrants with subordinated convertible promissory note at exercise price of $1.41 with the expiry on September 22, 2027.

     

    35
     

     

    On November 22, 2022, the Company had issued 984,557 warrants with subordinated convertible promissory note at exercise price of $1.41with the expiry on April 21, 2028.

     

    As part of the acquisition of Western, during the three months ended March 31 2025, the Company issued to unaffiliated investors a total of 7,272,728 series D warrants in exchange of existing 1,181,468 series D warrants having expiry on February 19, 2029 and exercise price of $0.50

     

    Other Warrants

     

    On March 8, 2022, the Company had issued 529,067 warrants to the originators of $700,000 of investor notes at exercise price of $0.92 with the expiry on March 8, 2026.

     

    As part of the acquisition of Western, during the three months ended March 31 2025, the Company issued to unaffiliated investors a total of 270,171 warrants in exchange of existing 529,067 warrants having expiry on February 19, 2029 and exercise price of $0.319707

     

    A summary of activity for all warrants during the three months ended March 31, 2025 as follows:

     

     SCHEDULE OF WARRANTS ACTIVITY

               Weighted 
       Number of   Weighted Average   Average 
       shares   Exercise Price   Life (years) 
    Outstanding, December 31, 2024   9,450,840   $0.69    3.04 
    Granted   26,099,773    5.50    4.69 
    Replacement of old warrants   (9,450,840)   0.69    2.92 
    Exercised   (7,044,917)   0.48    - 
    Expired   -    -    - 
    Outstanding, March 31, 2025   19,054,856   $7.36    4.66 
                    
    Exercisable, March 31, 2025   19,054,856   $7.36    4.66 

     

    The Company has accounted for the issuance of common stock and warrants issued for cash proceeds in the private placements as equity instruments. Management believes that the warrants are indexed to and are settled in the Company’s own common stock; therefore, they should be accounted for as permanent equity.

     

    NOTE 14 — LEASE COMMITMENTS

     

    Operating lease

     

    After the acquisition of Cloudburst, the Company entered into a new non-cancelable operating lease agreement with Scandium, LLC, for the lease of a new floor in the same building as it had occupied. This new lease agreement commenced on December 1, 2019 and expires in 48 months. The monthly rent for the first year was $10,351, the second year was $10,687, the third year was $11,035, and the fourth year was $11,393. The agreement calls for a security deposit of $10,351. As of March 31, 2025, and December 31, 2024, the Company does not have leases.

     

    The Company recognized total lease expense of $0, for the three months ended March 31, 2025 and 2024, primarily related to operating rent lease costs paid to lessors.

     

    36
     

     

    NOTE 15 — RISKS

     

    Credit risk

     

    The Company’s primary bank deposits are located in the United States. Those deposits are provided protection under FDIC insurance up to maximum of $250,000. Any deposits in excess of the aforementioned maximum are at risk of loss if those banks become insolvent.

     

    The Company is subject to risk borne from credit extended to customers.

     

    Interest risk

     

    The Company is subject to interest rate risk when its loans become due and require refinancing or if the prime rate adjusts, as the Company’s loans are based on adjustable interest rates.

     

    Inflation risk

     

    Management monitors changes in prices levels. Historically, inflation has not materially impacted the Company’s financial statements; however, significant increases in the cost of labor that cannot be passed on to the Company’s customers could adversely impact the Company’s results of operations.

     

    Concentration risks

     

    The following table sets forth information as to each customer that accounted for 10% or more of the Company’s revenues for the three months ended March 31, 2025 and 2024. Accordingly, there was a concentration of risk in demand for the Company’s services.

     

     SCHEDULE OF CONCENTRATION RISKS

        Revenue 
        For the three months ended March 31, 
        2025   2024 
    Customer   Amount   %   Amount   % 
    A   $3,368,125    87%  $3,741,079    88%
    B   $233,174    6%  $247,484    6%
    C   $142,888    4%  $78,551    2%

     

        Accounts receivable 
        At March 31,   At December 31, 
        2025   2024 
    Customer   Amount   %   Amount   % 
    1   $933,126    24%  $8,970,298    87%
    2   $771,596    20%  $342,394    3%
    3   $579,610    15%  $340,179    3%

     

    37
     

     

    NOTE 16 — FINANCIAL INSTRUMENTS

     

    The Company classified the following securities as financial instruments:

     SCHEDULE OF FINANCIAL INSTRUMENTS

      Level 1   Level 2   Level 3   Total 
       March 31, 2025 
      Level 1   Level 2   Level 3   Total 
    Liabilities:                
    Subordinated convertible promissory notes  $   -   $     -   $2,798,217   $2,798,217 

     

    Liabilities:  Level 1   Level 2   Level 3   Total 
       December 31, 2024 
    Liabilities:  Level 1   Level 2   Level 3   Total 
    Subordinated convertible promissory notes  $   -   $   -   $5,490,324   $5,490,324 
    Series A convertible preferred stock  $-   $-   $1,294,117   $1,294,117 
    Equity:                    
    Warrants  $-   $-   $2,687,074   $2,687,074 

     

    Management believes the carrying values of the above securities approximate their fair values. The subordinated convertible promissory notes carry an interest rate that is indicative of the Company’s overall borrowing cost and the length of time until maturity is not expected to significantly impact their value. The convertible preferred stock, which is akin to debt, has been discounted to its presented carrying value in accordance with the debt discounts and redemption premiums recognized.

     

    NOTE 17 — RELATED PARTY TRANSACTIONS

     

    Promissory Note – Related Party

     

    On September 20, 2024, the Company entered into a promissory note with the Sponsor for $230,000, pursuant to which the Company can borrow up to an aggregate principal amount of $230,000. The Promissory Note, with an interest rate of 10% per annum is payable upon the sooner of the consummation of the Business Combination with Cycurion. As of March 31, 2025, the Company had borrowed the full $230,000 and nothing was available for withdrawal. The Company deemed the interest on the loan to be immaterial and as such did not record any interest relating to the note as of March 31, 2025.

     

    Personal guarantees were entered by Emmit McHenry, Kurt McHenry, and Alvin McCoy III, as officers and stockholders of the Company in support of the Main Street Bank loan.

     

    Axxum purchased an AT&T contract relationship from Archura, LLC, a company owned by Emmit McHenry and Kurt McHenry at the end of 2018. The contract relationship includes five purchase orders to deliver networking services to AT&T and its clients. The total sales of these five purchase orders were $20,614.95 and $119,279, as of March 31, 2025 and December 31, 2024, respectively.

     

    38
     

     

    Loans payable

     

    The following table summarizes the components of the Company’s loans payable related parties as of March 31, 2025 and December 31, 2024:

     

    SCHEDULE OF RELATED PARTY TRANSACTIONS 

       March 31,   December 31,   Stated   Maturity 
       2025   2024   interest   (Calendar year) 
                     
    Loans to two directors issued in 2023  $130,900   $130,900    24%   2023 
    Loan to a director issued in 2024   20,250    20,250    24%   2025 
    Total face value   151,150    151,150           
    Unamortized discount and issuance costs   (1,749)   (3,062)          
    Total loans payable related parties  $149,401   $148,088           
                         
    Loans payable - current  $149,401   $148,088           
    Loans payable - non-current  $-   $-           

     

    During the three months ended March 31, 2025 and 2024, the Company record amortization of debt discount of $1,313 and $0, respectively.

     

    NOTE 18 — EARNINGS PER SHARE

     

    The components of basic and diluted Earnings Per Share (“EPS”) were as follows:

     

     SCHEDULE OF COMPONENTS OF BASIC AND DILUTED EARNINGS PER SHARE

       2025   2024 
       Three months ended 
       March 31, 
       2025   2024 
             
    Basic Loss per Share Numerator          
    Net Loss  $(10,248,486)  $(312,475)
    Loss Available to Common Stockholders   (10,248,486)   (312,475)
               
    Diluted Loss per Share Numerator          
    Add back interest for subordinated convertible promissory note   5,000    71,667 
               
    Loss Available to Common Stockholders on Converted Basis  $(10,243,486)  $(240,808)
               
    Original Shares:          
    Basic Weighted Average Shares Outstanding   18,271,618    14,863,215 
               
    Dilutive Shares:          
    Additions from Potential Events          
    - Conversion of Subordinated Convertible Promissory Note   100,000    1,736,533 
    - Conversion of Series A Convertible Preferred Stock   2,317,268    2,106,075 
    - Conversion of Series B Convertible Preferred Stock   1,142    4,000,000 
    - Conversion of Series C Convertible Preferred Stock   36,045    36,045 
    - Conversion of Series D Convertible Preferred Stock   76,667    - 
    - Conversion of Series E Convertible Preferred Stock   1    - 
    - Conversion of Convertible Preferred Stock   1    - 
    - Exercise of Investor and Placement Agent Warrants   19,054,856    7,450,840 
    Diluted Weighted Average Shares Outstanding:   39,857,597    30,192,708 
               
    Loss per Share          
    - Basic  $(0.56)  $(0.02)
    - Diluted  $(0.56)  $(0.02)

     

    39
     

     

    NOTE 19- COMMITMENTS AND CONTINGENCIES

     

    Registration Rights

     

    The holders of Founder Shares, Private Placement Units, and units that may be issued upon conversion of Working Capital Loans, if any, are entitled to registration rights pursuant to a registration rights agreement that was signed on the date of the IPO. These holders will be entitled to certain demand and “piggyback” registration rights. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until the termination of the applicable lock-up period for the securities to be registered. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

     

    Business Combination Marketing Agreement

     

    The Company entered into a business combination marketing agreement on January 11, 2022 (the “Business Combination Marketing Agreement”) with Alliance Global Partners/A.G.P. (“A.G.P.”) whereby A.G.P. is to act as an advisor in connection with a Business Combination to assist the Company in holding meetings with its stockholders to discuss the potential Business Combination and the target business’ attributes, introduce the Company to potential investors that are interested in purchasing the Company’s securities in connection with a Business Combination, assist the Company in obtaining stockholders’ approval for a Business Combination, and assist the Company with its press releases and public filings in connection with a Business Combination. The Company was to pay A.G.P. a fee for such marketing services upon the consummation of a Business Combination in an amount equal to 4.5% of the gross proceeds of the IPO, or $5,175,000 in the aggregate (exclusive of any applicable finders’ fees that might become payable). The Business Combination Marketing Agreement will be terminated upon entry into the Advisory Agreement (described below).

     

    Advisory Agreement with A.G.P.

     

    A.G.P. was a financial advisor to both Western in connection with the Business Combination transaction. Upon the completion of the Business Combination, A.G.P.: (i) received a cash fee of $500,000 shares of common stock and warrants to purchase 500,000 shares of common stock at an exercise price of $5.00 per share. Pursuant to the advisory agreement (the “Advisory Agreement”), Western shall pay A.G.P. a total transaction fee equal to $2,500,000 (the “Transaction Fee”) upon the closing of the Business Combination. The Transaction Fee will be payable in the form of preferred shares of Cycurion that are convertible into 500,000 shares of common stock (such preferred shares or the common stock into which they convert, the “Transaction Fee Shares”), for a price per share of common stock equal to $5.00. A portion of the Transaction Fee Shares shall be subject to forfeiture and return to the Company for cancellation once A.G.P. converts and sells Transaction Fee Shares generating sales proceeds (excluding commissions) of $2,500,000.

     

    Agreements with Seward & Kissel LLP

     

    November 27, 2024, we entered into a revised engagement letter (the “Revised Engagement Letter”) with Seward & Kissel LLP (“Seward & Kissel”), pursuant to which Western and Cycurion agreed to pay approximately $1.3 million of its outstanding legal fees and expenses (“Legal Fees”) in shares of common stock in connection with the Business Combination. Following the closing of the Business Combination on February 14, 2025 and in connection with the Revised Engagement Letter, we issued to Seward & Kissel 250,000 shares of common stock and a pre-funded warrant that is exercisable for approximately $1.3 million in shares of common stock (the “Seward & Kissel Pre-Funded Warrant”); provided that once the net proceeds from the sale of the shares equals the Legal Fees, the remaining shares of common stock, including such common stock exercisable under the Seward & Kissel Pre-Funded Warrant, shall be returned to the Cycurion. We plan to enter into an exchange agreement with Seward & Kissel to exchange the Seward & Kissel Pre-Funded Warrant for a convertible promissory note that is convertible into such number of shares equal to the Legal Fees.

     

    Agreement with Baker & Hostetler LLP

     

    In 2023, Western agreed to pay approximately $788,030 of its obligations to its counsel, Baker Hostetler LLP, in shares of common stock following the Business Combination, which will be issued at a price per share equal to $10.00, or 78,803 shares.

     

    Equity Line of Credit

     

    Equity Purchase Agreement

     

    On April 7, 2025 (the “Execution Date”), we entered into the Equity Purchase Agreement with the Investor. Under the Equity Purchase Agreement, we have the right, but not the obligation, to direct the Investor to purchase up to $60 million (the “Maximum Commitment Amount”) in shares of our common stock upon satisfaction of certain terms and conditions contained in the Equity Purchase Agreement, including, without limitation, an effective registration statement filed with the SEC registering the resale of the shares of Put Stock (defined below) and the shares of Commitment Stock (defined below) and additional shares to be sold to the Investor from time to time under the Equity Purchase Agreement. The term of the Equity Purchase Agreement began on the Execution Date and ends on the earlier of (i) the date on which the Investor shall have purchased shares of common stock issued, or that we shall be entitled to issue, per any applicable Put Notice in accordance with the terms and conditions of the Equity Purchase Agreement (the “Put Stock”) equal to the Maximum Commitment Amount, (ii) the date that is twelve (12) months from the date the registration statement is declared effective, (iii) written notice of termination by us to the Investor (which shall not occur at any time that the Investor holds any of the shares of Put Stock), or (iv) written notice of termination by the Investor to us pursuant to (the “Commitment Period”).

     

    40
     

     

    During the Commitment Period, we may direct the Investor to purchase shares of Put Stock by delivering a notice (a “Put Notice”) to the Investor. We shall, in our sole discretion, select the number of shares of Put Stock requested in each Put Notice. However, such amount may not exceed the Maximum Put Amount (as defined in the Equity Purchase Agreement). The purchase price to be paid by the Investor for the shares of Put Stock will be ninety percent (90%) of the lowest trade of the common stock on the Principal Market during the Valuation Period (as defined in the Equity Purchase Agreement).

     

    In consideration for the Investor’s execution and delivery of, and performance under the Equity Purchase Agreement, on the Execution Date, we, in our discretion, either were to (i) pay to the Investor in cash $1,800,000 (“Commitment Cash”) or (ii) issue the Pre-Funded Warrant to the Investor in a form acceptable to the Investor in its sole discretion and having an exercise price per share of $0.0001, for the Investor’s purchase of shares of common stock (the “Commitment Stock”) having a value of $1,800,000 based on closing price of the common stock on April 6, 2025. We chose to issue the Pre-Funded Warrant. All of the shares of Commitment Stock were fully earned as of the Execution Date, and the issuance of the shares of Commitment Stock is not contingent upon any other event or condition, including, without limitation, the effectiveness of the Initial Registration Statement (defined below) or our submission of a Put Notice to the Investor and irrespective of any termination of the Equity Purchase Agreement.

     

    Under the Equity Purchase Agreement, we are obligated to file with the SEC, on or before May 7, 2025, a registration statement on Form S-1 (the “Initial Registration Statement”) covering only the resale of the shares of Put Stock and Commitment Stock and is to use our best efforts to have the Initial Registration declared no later than July 7, 2025.

     

    Pre-Funded Warrant

     

    The Pre-Funded Warrant certifies that, for value received, the Investor is entitled to be issued up to 4,500,000 shares of common stock as its Commitment Fee and has an initial exercise price of $0.0001 per share. The Pre-Funded Warrant may not be exercised if the aggregate number of shares of the common stock beneficially owned by the holder would exceed 4.99% immediately after exercise thereof, which ownership cap may be increased by the holder up to 9.99% upon 61 days’ prior notice (the “Beneficial Ownership Limitation”).

     

    Registration Rights Agreement

     

    On April 7, 2025 (the “RRA Execution Date”), in connection with the Equity Purchase Agreement, we entered into a registration rights agreement with the Investor (the “Registration Rights Agreement”), pursuant to which we shall, by May 7, 2025, file with the SEC the Initial Registration Statement covering the maximum number of (i) shares of Commitment Stock, (ii) shares of Put Stock, which have been, or which may, from time to time be issued, including without limitation all of the shares of common stock which have been issued or will be issued to the Investor under the Equity Purchase Agreement (without regard to any limitation or restriction on purchases), and (iii) any and all shares of capital stock issued or issuable with respect to the Put Stock, Commitment Stock, and the Equity Purchase Agreement as a result of any stock split, combination, stock dividend, recapitalization, exchange, or similar event, or otherwise, without regard to any limitation on purchases under the Equity Purchase Agreement (the “Registrable Securities”), as shall be permitted to be included thereon in accordance with applicable SEC rules, regulations, and interpretations so as to permit the resale of the Registrable Securities by the Investor, including, but not limited to, under Rule 415 at then-prevailing market prices (and not fixed prices). The Initial Registration Statement shall register only Registrable Securities. We shall use our commercial best efforts to have the Initial Registration Statement and any amendment thereto declared effective by the SEC at the earliest possible date, but in no event later than July 7, 2025.

     

    Non-Redemption Agreement

     

    On August 6, 2024, the Company, Western Acquisition Ventures Sponsor, LLC (the “Sponsor”) and RiverNorth SPAC Arbitrage Fund, LP (the “RiverNorth”) entered into a non-redemption agreement (the “Non-Redemption Agreement”) whereby the Sponsor plans to transfer to the Investor 5,000 shares each month over the next three months for agreeing not to redeem the 99,800 that it currently holds prior to the business combination.

     

    On October 9, 2024, the Company, the Sponsor and RiverNorth entered into extended non-redemption agreement whereby the Sponsor plans to transfer to RiverNorth 5,000 shares each month over the next three months for agreeing not to redeem the 99,800 that it currently holds prior to the business combination.

     

    Employment Agreements

     

    On December 27, 2023, we entered into an employment agreement with James P. McCormick whereby the Company agreed to pay a total of $125,000 of total compensation annually, including $40,000 in cash and $85,000 in stock payment. On October 30, 2024, we entered into an amendment to the employment agreement with James P. McCormick whereby the Company agreed to pay total compensation of $200,000, including $40,000 in cash at the closing of the Business Combination and the remaining $160,000 in cash from the proceeds that the Company receives from any capital raising transaction following the closing of the Business Combination, including the proceeds from an equity line of credit to be entered into by and among the Company, Cycurion and the investors named therein; provided that the Company shall only be obligated to apply up to 15% of the proceeds from each capital raise until Mr. McCormick’s compensation of $200,000 has been paid in full.

     

    On December 1, 2024, Cycurion and L. Kevin Kelly, Chief Executive Officer, entered into an employment agreement on a two-year term, commencing on December 1, 2024 and ending on December 1, 2026. During the employment period, Mr. Kelly will receive an annual base salary of $325,000, and equity compensation of $500,000 of Company common stock in the first year of the employment agreement, payable quarterly. Mr. Kelly is eligible for a performance bonus based on the Company’s results. The targeted performance bonus is $325,000 for year-one, and the performance bonus will increase for subsequent years based on future financial and non-financial results.

     

    41
     

     

    On January 1, 2025, Cycurion and Alvin McCoy, III, Chief Financial Officer, entered into an employment agreement on a two-year term, commencing on January 1, 2025 and ending on December 31, 2026. During the employment period, Mr. McCoy, III will receive an annual base salary of $325,000 and equity compensation of $500,000 of Company stock in the first year of the employment agreement, payable quarterly. Mr. McCoy, III is eligible for a performance bonus based on the Company’s performance. The targeted performance bonus is $325,000 for year-one, and the performance bonus will increase for subsequent years based on future financial and non-financial results.

     

    Inflation Reduction Act of 2022 (the “IR Act”)

     

    On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax.

     

    Any redemption or other repurchase that occurs after December 31, 2022, in connection with a business combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a business combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the business combination, extension or otherwise, (ii) the structure of a business combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a business combination (or otherwise issued not in connection with a business combination but issued within the same taxable year of a business combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a business combination and in the Company’s ability to complete a business combination.

     

    As of March 31, 2025 and December 31, 2024, the Company’s stockholders have redeemed a total of 11,421,017 and 11,326,121 shares of common stock resulting in $1,167,174 and $1,157,161 of excise tax liability, calculated as 1% of the value of the shares redeemed, respectively

     

    NOTE 20 — SUBSEQUENT EVENTS

     

    The Company evaluates subsequent events that have occurred after the balance sheet date but before the financial statements are issued which is up to and through June 5, 2025. There are two types of subsequent events: (i) recognized, or those that provide additional evidence with respect to conditions that existed at the date of the balance sheet, including the estimates inherent in the process of preparing consolidated financial statements, and (ii) non-recognized, or those that provide evidence with respect to conditions that did not exist at the date of the balance sheet but arose subsequent to that date.

     

    On April 7, 2025, Cycurion entered into an equity purchase agreement with Yield Point NY LLC whereby the Company has the right, but not the obligation, to direct the investor to purchase up to $60,000,000.

     

    On April 8, 2025, Cycurion announced an expanded partnership with Journal Technologies. Together, the companies have been awarded a $22 million multi-year contract to deliver a criminal justice case management system to a state police agency.

     

    On April 9, 2025, Cycurion increased the size of its board of directors through the appointment of Irving Minnaker.

     

    On April 9, 2025, Cycurion received written notice received from the Listing Qualifications Department of Nasdaq stating that, for the prior 30 consecutive business days, the closing bid price of the Company’s common stock had been below the minimum of $1 per share required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2). The notification letter stated that the Company would be afforded 180 calendar days (until October 6, 2025) to regain compliance. In order to regain compliance, the closing bid price of the Company’s common stock must be at least $1 for a minimum of ten consecutive business days. The notification letter also stated that, in the event the Company does not regain compliance within the initial 180-day period, the Company may be eligible for an additional 180-day period. If the Company is not eligible for the additional 180-day period, or if it appears to the Nasdaq staff that the Company will not be able to cure the deficiency, the Nasdaq Listing Qualifications Department will provide notice after the end of the initial 180-day period that the Company’s securities will be subject to delisting. The Nasdaq notification has no effect at this time on the listing of the Company’s common stock.

     

    42
     

     

    On April 11, 2025, we received two letters from the Nasdaq Listing Qualifications Department, each addressing a separate compliance deficiency of the Company under the Nasdaq Listing Rules. The first letter from the Nasdaq Listing Qualifications Department notified us of our non-compliance with Nasdaq Listing Rule 5450(b)(2)(A), which requires a company such as ours whose securities are listed on The Nasdaq Global Market under the “Market Value Standard” to maintain a minimum Market Value of Listed Securities (an “MVLS”) of $50,000,000. The deficiency was triggered by our MVLS having closed below the minimum level for a period of 30 consecutive business days. Under Nasdaq Listing Rule 5810(c)(3)(C), we are entitled to a 180-day period, ending on October, 2025, to rectify the deficiency. In order to do so, we must achieve and maintain an MVLS of $50,000,000 or more for at least 10 consecutive business days. Failure to regain compliance within the 180-day period would result in the delisting of our securities from Nasdaq, although we would have the right to appeal such a delisting to a Nasdaq hearings panel.

     

    The second letter informed us of our deficiency in complying with Nasdaq Listing Rule 5450(b)(2)(C), which requires a minimum Market Value of Publicly Held Shares (an “MVPHS”) of $15,000,000 for continued listing on the Nasdaq Global Market under the “Market Value Standard”. This deficiency was caused by our MVPHS having fallen below the minimum threshold for the prior 30 consecutive business days. Under Nasdaq Listing Rule 5810(c)(3)(D), we have 180 calendar days, or until October 8, 2025, to regain compliance, which we can achieve if its MVPHS closes at or above $15,000,000 for at least 10 consecutive business days. Failure to regain compliance within that 180-day period would result in the delisting of our securities from Nasdaq, subject to our right to appeal to a Nasdaq hearings panel.

     

    On April 29, 2025, Cycurion issued a press release announcing that the Company has been awarded a $6 million contract by a major municipal agency.

     

    On May 22, 2025, Cycurion received written notice indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”) as a result of its failure to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2025 (the “Form 10-Q”), as described more fully in the Company’s Form NT 10-Q Notification of Late Filing (the “Form NT 10-Q”) filed with the SEC on May 15, 2025. The Listing Rule requires Nasdaq-listed companies to timely file all required periodic reports with the SEC.

     

    The Notice has no immediate effect on the listing or trading of the Company’s common stock on the Nasdaq Global Select Market.

     

    In accordance with Nasdaq’s listing rules, the Company has 60 calendar days after the Notice to submit a plan to regain compliance with the Listing Rule. Pursuant to the Notice, following receipt of such plan, Nasdaq may grant an extension of up to 180 calendar days from the Form 10-Q’s due date, or until November 17, 2025, for the Company to regain compliance. The Company intends to take the necessary steps to regain compliance with Nasdaq’s listing rules as soon as practicable.

     

    From April 1 to May 30, 2025, otherwise unaffiliated persons converted 2,999.3 shares of the Company’s Series B Preferred Stock into 5,998,653 shares of the Company’s common stock and 150,000 shares of the Company’s Series D Preferred Stock into 150,000 shares of the Company’s common stock.

     

    From April 1 to May 30, 2025, otherwise unaffiliated persons exercised 694,530 Series A warrants for the purchase of 694,530 shares of the Company’s common stock; 2,400,000 Series B warrants for the purchase of 4,800,000 shares of the Company’s common stock; 4,382,033 Series D warrants for the purchase of 8,764,066 shares of the Company’s common stock for gross proceeds of approximately $3.5 million.

     

    43

     

     

    ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

     

    Throughout this section, unless otherwise noted, “we,” “our,” “us,” “Cycurion” and the “Company” refer to Cycurion, Inc.

     

    You should read the following discussion of our financial condition and results of operations in conjunction with our financial statements and the notes included elsewhere in this quarterly report on Form 10-Q. The following discussion contains forward-looking statements that involve certain risks and uncertainties. Our actual results could differ materially from those discussed in these statements. Factors that could cause or contribute to these differences include those discussed below and elsewhere in this quarterly report.

     

    Management’s plans and basis of presentation:

     

    We were originally incorporated as KAE Holdings, Inc., under the laws of the State of Delaware in 2017, with the purpose of acquiring and holding operating entities in the cybersecurity industry. On July 14, 2020, we changed our corporate name from KAE Holdings, Inc. to Cyber Secure Solutions, Inc., and, on February 24, 2021, to Cycurion, Inc.

     

    We have one first-tier wholly-owned subsidiary, Cycurion Sub, Inc. (formerly Cycurion, Inc., until February 14, 2025), and three indirectly wholly-owned second-tier subsidiaries: (i) Axxum Technologies LLC (“Axxum”), a Virginia limited liability company formed in December 2006, (ii) Cloudburst Security LLC (“Cloudburst”), a Virginia limited liability company formed in January 2007, and (iii) Cycurion Innovation, Inc., a Delaware corporation formed in September 2021, in connection with our acquisition of assets from Sabres Security Ltd. (“Sabres”), a leading Israeli-based cyber security provider.

     

    Our Business

     

    We deliver high-quality, cybersecurity solutions to federal government civilian, defense, and judiciary agencies in addition to commercial clients across a variety of industries. Through our operating subsidiaries and strategic partnerships, we have numerous prime and subcontracts with key government agencies. Our growth engine is driven by organic business solutions and strategic acquisitions of cyber/ infrastructure service providers.

     

    Our Subsidiaries

     

    Cycurion Sub, Inc.

     

    We own our operating subsidiaries through Cycurion Sub., Inc., a Delaware corporation that, until the closing date of the de-SPAC, was known as “Cycurion, Inc.” We continue to conduct our business through the three below-described entities, which are now indirectly wholly-owned second-tier subsidiaries by virtue of the recent closing of the de-SPAC transaction.

     

    Axxum Technologies LLC

     

    Organized in the Commonwealth of Virginia on December 29, 2006, Axxum is a cybersecurity provider with successful assignments within the multiple sub-agencies of the Department of Homeland Security. We acquired Axxum in November 2017. Following the acquisition, we continued Axxum’s core operations of providing contractor services to its existing federal government customer base while leveraging our existing processes and tools to expand its commercial footprint.

     

    44

     

     

    Cloudburst Security LLC

     

    Cloudburst is a cybersecurity provider with successful assignments within highly sensitive government agencies and other commercial organizations. We acquired Cloudburst in April 2019. Following the acquisition, we continued Cloudburst’s core operations of providing mission-critical and highly sensitive government agencies and other commercial organizations with high-quality, innovative cybersecurity services. Cloudburst focuses on providing tailored solutions that leverage the industry’s best minds and technologies to predict, protect, detect, respond, and sustain our clients from the latest evolving cyber threats.

     

    Cycurion Innovation, Inc.

     

    Cycurion Innovation, Inc. was formed in connection with our acquisition of assets from Sabres, a leading Israeli-based cyber security provider. It operates our Cycurion Security Platform’s line of products allows our customers to improve their cyber posture with its MDP SaaS platform. This platform efficiently bundles and easily implements the external protection of a Web Application Firewall (“WAF”) and the internal protection of Bot Mitigation. Bot Mitigation is the reduction of risk to applications, Application Program Interfaces (APIs), and backend services from malicious bot traffic that fuels common automated attacks, such as Distributed Denial of Service (“DDoS”) campaigns and vulnerability probing. The costs of single-layer security can be measured in terms of money, time, and risk, as well as the damage wrought by a data breach, which millions of businesses experience each year. Through this interaction of the WAF and Bot Mitigation, the MDP is able to reinforce these layers of security and generate new security layers in real time in response to emerging threats. This process is directed by our Cycurion Security Platform’s proprietary, cloud-based artificial intelligence (“AI”) algorithm. Crucially, the AI underpinning the MDP platform is constantly evolving to counter new threats. Through a crowdsourcing process, the cloud-based MDP learns from every threat to any protected application and uses that newly acquired knowledge to protect all MDP clients better.

      

    SLG Innovation, Inc.

     

    The SLG team has an average of over 25 years of experience in the development, planning, implementation, and management of information systems. SLG’s leadership team offers years of combined success in answering the needs of government agencies and healthcare organizations across the country.

     

    The SLG team has worked nationally, as it has served over 25 Department of Health and Human Services agencies, all 50 state governments, and over 250 local governments. Since SLG’s inception, it has primarily focused on customers in the middle of the country. The team of professionals has successfully delivered Information Technology, Project Management, and Subject Matter Services to key health and human service projects, including, but not limited to, state Medicaid programs in Illinois, Indiana, Nebraska, and Tennessee, the Indiana Division of Aging, Illinois Early Intervention, the University of Illinois Division of Specialized Care for Children, the Multiple Myeloma Research Foundation, and many more.

     

    We established a subcontractor — prime contractor relationship with SLG in the fall of 2019, where we serviced several government agencies and commercial customers, State of New Mexico, Cognizant, KPMG, and the University of Illinois in support of SLG. Axxum Technologies and SLG Innovation that relationship in 2020. A subcontractor offers its specialized services to a prime contractor. Unlike prime contractors, who focus on the managerial side of the government contract, subcontractors tend to dedicate their efforts to lending subject matter expertise and delivery of service to the project. Technically strong subcontractors, along with a strong subcontractor plan are essential to boost the success of a project.

     

    As a result of the strong technical skills and experience of the cyber teams at Cycurion and its subsidiaries, SLG Innovation entered into a Master Services Agreement (MSA) with Axxum Technologies to provide services to SLG customers. The MSA is task order driven and the number of task orders is modified periodically depending on actual customer requirements for IT and Cybersecurity services. Over the last three years, Axxum Technologies has assisted SLG Innovation in growing its revenue and customer base. As a result, SLG Innovation now represents a majority of Cycurion revenues.

     

    SLG Acquisition Agreement

     

    Our revenues from SLG in our 2024 and 2023 fiscal years were $14,703,887 and $13,837,042, respectively. The types of agreements to which SLG is a party are discussed under the heading “Our Business — Key Clients and Historical Performance.” From our perspective, a major benefit to us of the potential transaction contemplated by the SLG Term Sheet, as described below, would be that we could “piggyback” on SLG’s historical relationships with the various contracting governmental agencies in our bidding on future potential agreements. It is axiomatic in the governmental contracting arena in which we are involved that past performance on customer assignments as the prime contractor is one of the more important qualifications in competing for new opportunities within the federal government. We believe that our acquisition of SLG, if that transaction is closed by us, would yield such “past performance” qualifications.

     

    On April 25, 2023, Cycurion Sub executed a Term Sheet with SLG (the “SLG Term Sheet”), pursuant to which SLG agreed to be acquired by Cycurion Sub. The Term Sheet contained all of the material terms and conditions of two proposed interrelated transactions to be memorialized by the SLG Acquisition Agreeement. To effectuate the two transactions contemplated by the SLG Term Sheet, Cycurion Sub will form two subsidiaries, which, upon formation, will initially be wholly owned by Cycurion Sub. If, when, and as the transactions contemplated by the SLG Term Sheet are consummated, SLG would merge with and into one of the subsidiaries and survive, thereby becoming a wholly-owned subsidiary of Cycurion Sub. Because certain of the agreements to which SLG is the prime contractor require that the majority owner of the prime contractor be a resident of the City of Chicago or of Cook County (depending on the contract), contemporaneously with the consummation of the first of the two transactions, (i) SLG will divest itself of those agreements with the residency requirements, (ii) the second newly formed subsidiary will assume those agreements, (iii) Mr. Ed Burns will become the owner of a 51% interest in that newly formed subsidiary, and (iv) we will enter into a Management Agreement with that subsidiary, the economic terms and management/ control terms of which are intended to be the equivalent of complete ownership of that the 49% owned subsidiary. Mr. Ed Burns is currently the 51% owner of SLG and a resident of the City of Chicago. The SLG Term Sheet provides that, if, when, and as the transactions contemplated thereby are consummated, the two current owners of SLG will be issued an aggregate of 996,355 shares of Cycurion common stock.

     

    SLG is fully bound by the terms and provisions of the SLG Term Sheet and the related Management Agreement structure, although Cycurion Sub is permitted to terminate the SLG Term Sheet and to abandon the transactions contemplated thereby any time for any reason or for no reason prior to April 11, 2025, with no further obligations on Cycurion Sub’s part. As of the date of this quarterly report, although we reserve the right to modify the terms and provisions of the SLG Acquisition Agreement, we do not currently expect to terminate it and currently expect to close the transactions contemplated during our current fiscal quarter. Substantially all of the agreements to which SLG is a party have a provision that provides the counterparty to such agreement with a right to approve an assignment or change in control of SLG prior to its effectiveness. If an approval is not forthcoming, then the provisions of the SLG Acquisition Agreement permit us to excise that specific agreement. Upon such occurrence, we reserve that right to reduce the consideration that we would otherwise tender to the equity owners of SLG.

     

    45

     

     

    As amended by the parties, initially effective as of November 29, 2023 and subsequently effective as of April 29, 2024, August 16, 2024 and December 31, 2024, the SLG Term Sheet expires on the soonest of (i) closing of the transactions contemplated thereby, (ii) April 11, 2025, if the transactions contemplated thereby have not closed by then, (iii) Cycurion Sub’s termination thereof, and (iv) the mutual termination by all of the parties thereto. Notwithstanding anything to the contrary contained therein, Cycurion Sub may terminate its obligations under the SLG Term Sheet and the transactions contemplated hereby for any reason or for no reason without any further obligations and without any liability at any time through and including April 11, 2025. The SLG Term Sheet, as amended, consensually superseded, as noted therein, Cycurion Sub’s previous “unidirectional” agreements with SLG.

     

    The foregoing brief summary description of certain terms and provisions of (i) the SLG Term Sheet does not purport to be complete and is qualified in its entirety by reference to the full text of the SLG Term Sheet, a copy of which is attached to this Annual Report as Exhibit 10.12, (ii) the SLG Term Sheet Amendments, a copy of each of which is attached to this Annual Report as Exhibit 10.12a, Exhibit 10.12b, Exhibit 10.12c, and Exhibit 10.12d, and (iii) the SLG Management Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the SLG Term Sheet, a copy of which is attached to the Annual Report on Form 10-K filed with the SEC on April 17, 2025 as Exhibit 10.12e. Readers are encouraged to read those Exhibits in full for a more comprehensive understanding of the transaction contemplated by the SLG Term Sheet.

     

    RCR Acquisition Agreement

     

    RCR Technology Corporation (“RCR”) performs certain services for SLG in its role as an SLG subcontractor and, in that context, became a creditor of SLG. In connection with the transactions contemplated by the SLG Term Sheet, on April 25, 2023, Cycurion and RCR also entered into a term sheet (the “RCR Term Sheet”) for a distinct, but related transaction. The RCR Term Sheet contemplates a transaction, pursuant to which RCR will sell to Cycurion all of the accounts receivable of SLG in favor of RCR (but for those accounts that are less than 90 days old as of the date of consummation of the contemplated transaction). The consummation of the transactions contemplated by the RCR Term Sheet is contingent upon the consummation of the transactions contemplated by the SLG Term Sheet. Nevertheless, as a result of our entry into the SLG Management Agreement with SLG, we still currently intend to consummate the transactions contemplated by the RCR Term Sheet in the second half of our current fiscal year. The RCR Term Sheet provides that, if, when, and as the transactions contemplated thereby are consummated, RCR will be issued shares of our common stock.

     

    Further, as amended by the parties, initially effective as of November 29, 2023, and subsequently effective as of April 29, 2024, August 16, 2024 and December 31, 2024, the RCR Term Sheet expires on the soonest of (i) closing of the transactions contemplated thereby, (ii) April 11, 2025, if the transactions contemplated thereby have not closed by then, (iii) Cycurion’s termination thereof, and (iv) the mutual termination by all of the parties thereto. Notwithstanding anything to the contrary contained therein, Cycurion may terminate its obligations under the RCR Term Sheet and the transactions contemplated hereby for any reason or for no reason without any further obligations and without any liability at any time through and including April 11, 2025. As of the date of this quarterly report, we do not currently expect to terminate the transactions contemplated by the RCR Term Sheet, as amended, and currently expect to close the transactions in the second half of our current fiscal year.

     

    The foregoing brief summary description of certain terms and provisions of the RCR Term Sheet does not purport to be complete and is qualified in its entirety by reference to the full text of the RCR Term Sheet, a copy of which is attached to the Annual Report on Form 10-K filed with the SEC on April 17, 2025 as Exhibit 10.13 and the full text of the RCR Term Sheet Amendments, a copy of each of which are attached to the Annual Report on Form 10-K filed with the SEC on April 17, 2025 as Exhibit 10.13a, 10.13b and 10.13c. Readers are encouraged to read those Exhibits in full for a more comprehensive understanding of the transaction contemplated by the RCR Term Sheet.

     

    46

     

     

    Acquisition of Technology

     

    Sabres SaaS Asset Purchase

     

    On August 17, 2021, we entered into an asset purchase agreement to acquire certain technology assets of Sabres, a leading Israeli-based cyber security provider. As part of the asset purchase agreement, we acquired Multi-Dimensional Protection, Web Application Firewall and Bot Mitigation SaaS platforms, and their associated intellectual property. The transaction closed on September 30, 2021, and we have integrated the SaaS platforms into our existing services offerings.

     

    Our Cycurion Security Platform’s (formerly Sabres’) line of products allows our customers to improve their cyber posture with its MDP SaaS platform. This platform efficiently bundles and easily implements the external protection of a Web Application Firewall (WAF) and the internal protection of Bot Mitigation. Bot Mitigation is the reduction of risk to applications, Application Program Interfaces (APIs), and backend services from malicious bot traffic that fuels common automated attacks, such as DDoS campaigns and vulnerability probing. The costs of single-layer security can be measured in terms of money, time, and risk, as well as the damage wrought by a data breach, which millions of businesses experience each year. Through this interaction of the WAF and Bot Mitigation, the MDP is able to reinforce these layers of security and generate new security layers in real time in response to emerging threats. This process is directed by our Cycurion Security Platform’s proprietary, cloud-based AI algorithm. Crucially, the AI underpinning the MDP platform is constantly evolving to counter new threats. Through a crowdsourcing process, the cloud-based MDP learns from every threat to any protected application and uses that newly acquired knowledge to protect all MDP clients better.

     

    Our Cycurion Security Platform’s (formerly Sabres’) line of products provides solutions for substantially all web application security needs. These products provide solutions, whether a client is in need of a web application firewall to comply with regulations and ensure it has a first line of defense against the hazards that the internet can present or is in need of enterprise-level products that empower Security Operations Center (SOC) teams and security management. Our Cycurion Security Platform’s constantly survey a client’s data to detect security issues in need of attention, send automatic updates, and provide the client with a complete database of rules and threats.

     

    We have integrated the technology assets that we acquired from Sabres (which now constitutes our Cycurion Security Platform) into our Managed Security Services Practice. We believe that the platform will enhance our service offerings and assist with the expansion of our commercial business. The Sabres platform will be managed by our dedicated support team, and will provide real time reporting, response to security incidents, and will manage all data privacy needs from a single SIEM SaaS platform dashboard.

     

    47

     

      

    Results of Operations for the three months ended March 31, 2025 and 2024

     

    Three Months Ended March 31,

     

       2025   2024 
    Revenue   $3,870,050   $4,242,855 
    Cost of revenue    3,192,287    3,896,141 
    Gross profit   677,763    346,714 
    Selling, general and administrative    10,775,268    378,977 
    Interest and other expenses   (150,981)   (280,212)
    Net income/loss  $(10,248,486)  $(312,475)

     

    Revenue

     

    Revenues for the three months ended March 31, 2025, were $3,870,050, as compared to $4,242,855 for the three months ended March 31, 2024, a decrease of $372,805, representing 8.79% decrease in revenues.

     

    We attribute this decrease in the revenues for the three months ended March 31, 2025, to delayed start dates of new federal, state and local contracts and focus on more profitable business.

     

    Cost of Revenue

     

    The cost of revenue for the three months ended March 31, 2025, was approximately $3,192,287 nearly all of which is related to costs incurred while delivering services to our customers. Conversely, the cost of revenue for the three months ended March 31, 2024, was approximately $3,896,141, nearly all of which is related to costs incurred while servicing our contracts, including contractual and servicing obligations with our employees and contractors.

     

    This $703,854 (18.07%) decrease in the cost of revenues is directly attributable to reduced expenses brought about by the reduced revenue and more profitable business.

     

    Research and Development

     

    We did not have any Research and Development expenses for the three months ended March 31, 2025 and the three months ended March 31, 2024.

     

    Selling, General and Administrative

     

    Our selling, general and administrative (“SG&A”) expenses were $10,775,268 and $378,977 for the three months ended March 31, 2025 and 2024, respectively. We attribute this $10,396,291 (2743.25%) increase in SG&A expenses to merger and acquisition efforts in the legal, administrative, and consulting operations in the three months ended March 31, 2025.

     

    Interest and Other Expenses

     

    Interest and other expenses were approximately $150,981 for the three months ended March 31, 2025, while the Company had interest and other expenses of $280,212 for the three months ended March 31, 2024. The interest and other expenses for the three months ended March 31, 2025 include $178,890 in interest expense, $113,744 in other expense and $141,653 gain on settlement of debts.

     

    48

     

     

    Cash Flows

     

    The Three months Ended March 31

     

       2025   2024 
    Cash and cash equivalents at the beginning of the period  $40,790   $607,869 
    Net cash provided by (used in) operating activities   (2,745,109)   (272,446)
    Net cash provided by (used in) investing activities   1,799,523   (105,001)
    Net cash provided by financing activities   3,173,991    (23,483)
    Cash and cash equivalents at the end of the period  $2,269,195   $206,939 

     

    Operating Activities

     

    For the three months ended March 31, 2025, net cash used by operating activities was $2,745,109, which included $9,250,00 in stock based compensation, $1,300,686 decrease in accounts receivable, $467,761 decrease in accounts payable and $11,415 decrease in advance and pre-payments to suppliers.

     

    For the three months ended March 31, 2024, net cash used by operating activities was $272,446, which included $312,475 in net losses, $507,077 decrease in accounts receivable, $529,981 increase in accounts and other payables, and $10,000 increase in stock based compensation.

     

    Investing Activities

     

    For the three months ended March 31, 2025, net cash provided in investing activities was approximately $1,799,523. This was attributed to cash withdrawn from the Trust Account for redemption and cash released from the Trust Account to the Company.

     

    For the three months ended March 31, 2024, net cash used in investing activities was approximately $105,001. This was wholly attributed to the purchase of equipment.

     

    Financing Activities

     

    For the three months ended March 31, 2025, net cash provided by financing activities was $3,173,991. The net cash provided includes $3,309,921 proceeds provided from the exercise of warrants, $1,001,216 cash used in redemption of common stock for redemption, $513,200 in proceeds provided from notes payable, $386,500 in proceeds provided convertible noted payable and $20,000 used in the repayment of other notes payable.

     

    For the three months ended March 31, 2024, net cash used by financing activities was $23,483. The net cash used includes $16,980 in repayment of line of credit, $6,503 used in the repayment of bank borrowings.

     

    Liquidity and Capital Resources

     

    Going Concern

     

    We have incurred operating losses since inception through the period ended March 31, 2025, having had negative cash flow from operations. As of March 31, 2025, we had an accumulated deficit of approximately $13,461,859, as compared to our accumulated deficit of approximately $3,203,361 at December 31, 2024. The increase of our accumulated deficit was a result of our net losses for the three months ended March 31, 2024.

     

    Furthermore, we expect continued, significant operating losses for the next few years. We also utilized cash in operations of approximately $2,745,109 in the three months ended March 31, 2025. As of March 31, 2025, we had unrestricted cash of approximately $2.3 million, an increase of $2.2 million from approximately $38,000 at December 31, 2024. As of March 31, 2025, our total assets increased to approximately $31.6 million from approximately $25.6 million at December 31, 2024, primarily due to increases in goodwill. Based on our current capital resources as of March 31, 2025, including our unrestricted cash and accounts receivable (net) of $3.9 million, we expect to be able to continue our operations for a minimum of 12 months as of the date of this quarterly report. Nevertheless, our continuation as a going concern is dependent on our ability to obtain additional financing until we can generate sufficient, consistent cash flow from operations to meet the expected growth in our obligations. We intend to continue to seek additional debt or equity financing to continue our operations.

     

    Our consolidated financial statements have been prepared on a going concern basis, which implies we may not continue to meet our obligations and continue our operations for the next fiscal year. The continuation of our Company as a going concern is dependent upon our ability to obtain necessary debt or equity financing to continue operations until we begin generating positive cash flow.

     

    49

     

     

    There is no assurance that we will ever be consistently profitable or, notwithstanding our recent financing activities, that debt or equity financing will be available to us in the amounts, on terms, and at times deemed acceptable to us, if at all. The issuance of additional equity securities by us would result in a significant dilution in the equity interests of our current stockholders. Obtaining commercial loans, assuming those loans would be available, would increase our liabilities and future cash commitments. If we are unable to obtain financing in the amounts and on terms deemed acceptable to us, we may be unable to continue our business, as planned, and as a result may be required to scale back or cease operations for our business, the result of which would be that our stockholders would lose some or all of their investment. The consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result should we be unable to continue as a going concern.

     

    Off-balance sheet arrangements

     

    We did not have any off-balance sheet arrangements during the periods presented, and we do not currently have any off-balance sheet arrangements, as defined in the SEC rules and regulations.

     

    Critical accounting policies and significant judgments and estimates

     

    Our financial statements are prepared in accordance with GAAP. The preparation of our financial statements requires us to make estimates, assumptions and judgments that affect the reported amounts of assets, liabilities, costs, and expenses. We base our estimates and assumptions on historical experience and other factors that we believe to be reasonable under the circumstances. We evaluate our estimates and assumptions on an ongoing basis. Our actual results may differ from these estimates. Our most critical accounting policies are summarized below. See Note 2 to our consolidated financial statements for the three months ended March 31, 2025 and 2024 for a description of our other significant accounting policies.

     

    Goodwill

     

    Goodwill represents the excess of the purchase price over the fair value of the net tangible and identifiable assets acquired in a business combination. Goodwill is reviewed for impairment annually during the fourth quarter of each fiscal year, or more frequently if impairment indicators arise. The review of goodwill impairment consists of either using a qualitative approach to determine whether it is more likely than not that the fair value of the assets is less than their respective carrying values or a one-step quantitative impairment test. In performing the qualitative assessment, we consider many factors in evaluating whether the carrying value of goodwill may not be recoverable. If, based on the results of the qualitative assessment, it is concluded that it is not more likely than not that the fair value of a reporting unit exceeds its carrying value, additional quantitative impairment testing is performed. The quantitative test requires that the carrying value of each reporting unit be compared with its estimated fair value. If the carrying value of a reporting unit is greater than its fair value, a goodwill impairment charge will be recorded for the difference (up to the carrying value of goodwill). Fair value is generally determined using a discounted cash flow analysis. During the three months ended March 31, 2025 and 2024, no impairment of goodwill was recognized.

     

    Software development costs

     

    The Company is undergoing new Software as a Service (“SaaS”) product development based on an acquired SaaS platform in previous years, which has not been utilized in its original form. Cost from the acquired SaaS platform, functionalities and modules and the redesigned features of the distinct new SaaS product are accounted for under ASC 985-20 (Costs of Software to Be Sold, Leased, or Marketed). Development costs were capitalized as “Software Development in Progress” after achieving technological feasibility.

     

    Accounting for long-lived assets

     

    The Company annually reviews its long-lived assets for impairment or whenever events or changes in circumstances indicate that the carrying amount of assets may not be recoverable. Impairment may be the result of becoming obsolete from a change in the industry or new technologies. Impairment is present if the carrying amount of an asset is less than its undiscounted cash flows to be generated.

     

    If an asset is considered impaired, a loss is recognized based on the amount by which the carrying amount exceeds the fair market value of the asset. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.

     

    Revenue Recognition

     

    We adopted the new revenue standard, ASC 606, on January 1, 2018, using the full retrospective approach. The adoption did not have an effect on 2023 or 2023 revenue recognition or a cumulative effect on opening equity, as the timing and measurement of revenue recognition is materially the same as under ASC 605. The core principle of the new revenue standard is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. The following five steps are applied to achieve that core principle:

     

    ●Step 1: Identify the contract with the customer
    ●Step 2: Identify the performance obligations in the contract
    ●Step 3: Determine the transaction price
    ●Step 4: Allocate the transaction price to the performance obligations in the contract
    ●Step 5: Recognize revenue when the company satisfies a performance obligation

     

    For contracts where the period between when we transfer a promised good or service to the customer and when the customer pays is one year or less, we have elected the practical expedient to not adjust the promised amount of consideration for the effects of a significant financing component.

     

    Our performance obligation is to provide a development service that enhances an asset that the customer controls. We receive upfront payments in advance of providing services and payment upon reaching milestones.

     

    We are not able to reasonably measure the outcome of our performance obligations that are satisfied over time because we are in the early stages of the contracts. Therefore, the amount of performance that will be required in our contracts cannot be reliably estimated and we recognize revenue up to the amount of costs incurred.

     

    50

     

     

    Stock-based compensation

     

    We measure and recognize compensation expense for all options based on the estimated fair value of the award on the grant date. We use the Black-Scholes option- pricing model to estimate the fair value of option awards. The fair value is recognized as expense on a straight-line basis over the requisite service period. We account for forfeitures as they occur. We recognize expense for awards where vesting is subject to a market or performance condition based on the derived service period. Expense for awards with performance conditions would be estimated and adjusted on a quarterly basis based upon our assessment of the probability that the performance condition will be met.

     

    The determination of the grant date fair value of options using an option pricing model is affected principally by our estimated fair value of shares of our Common Stock and requires management to make a number of other assumptions, including the expected life of the option, the volatility of the underlying shares, the risk-free interest rate and expected dividends. The assumptions used in our Black-Scholes option- pricing model represent management’s best estimates at the time of measurement. These estimates are complex, involve a number of variables, uncertainties and assumptions and the application of management’s judgment, as they are inherently subjective. If any assumptions change, our stock-based compensation expense could be materially different in the future.

     

    These assumptions are estimated as follows:

     

    ●Fair Value of Common Stock. As our Common Stock has not historically been publicly traded, we estimated the fair value of our Common Stock. See “Fair Value of Common Stock” and “Common Stock Valuation Methodology” sections.
    ●Expected Term. The expected term represents the period that our options are expected to be outstanding. We calculated the expected term using the simplified method for options based on the average of each option’s vesting term and the contractual period during which the option can be exercised, which is typically 10 years following the date of grant.
    ●Expected Volatility. The expected volatility was based on the historical share volatility of several of our comparable publicly traded companies over a period of time equal to the expected term of the options, as we do not have any trading history to use the volatility of our Common Stock.
    ●Risk-Free Interest Rate. The risk-free interest rate was based on the yields of U.S. Treasury securities with maturities appropriate for the term of the award.
    ●Expected Dividend Yield. We have not paid dividends on our Common Stock nor do we expect to pay dividends in the foreseeable future.

     

    Fair Value of Common Stock

     

    Historically, for all periods prior to this offering, the fair values of the shares of Common Stock underlying our options were estimated on each grant date by our board of directors. In order to determine the fair value, our board of directors considered, among other things, contemporaneous valuations of our Common Stock and Preferred Stock prepared by unrelated third-party valuation firms in accordance with the guidance provided by the American Institute of Certified Public Accountants 2013 Practice Aid, Valuation of Privately-Held-Company Equity Securities Issued as Compensation, or the Practice Aid. Given the absence of a public trading market of our capital stock, our board of directors exercised reasonable judgment and considered a number of objective and subjective factors to determine the best estimate of the fair value of our Common Stock, including:

     

    ●contemporaneous third-party valuations of our Common Stock;
    ●the prices, rights, preferences, and privileges of our Preferred Stock relative to our Common Stock;
    ●our business, financial condition, and results of operations, including related industry trends affecting our operations;
    ●the likelihood of achieving a liquidity event, such as an initial public offering or sale of our company, given prevailing market conditions;
    ●the lack of marketability of our Common Stock;
    ●the market performance of comparable publicly traded companies; and
    ●U.S. and global economic and capital market conditions and outlook.

     

    Recent accounting pronouncements

     

    See Note 2 to our consolidated financial statements for the three months ended March 31, 2025 and 2024 for a description of recent accounting pronouncements applicable to our financial statements.

     

    51

     

     

    ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

     

    As a “smaller reporting company,” as that term is defined in Rule 229.10(f)(1), we are not required to provide the information required by this Item.

     

    ITEM 4. CONTROLS AND PROCEDURES

     

    Evaluation of Disclosure Controls and Procedures.

     

    We carried out an evaluation, under the supervision, and with the participation of our management, including our principal executive officer and principal financial officer, of the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)). Based upon that evaluation, our principal executive officer and principal financial officer concluded that, as of March 31, 2025, the period covered in this report, our disclosure controls and procedures were not effective to ensure that information required to be disclosed in reports filed under the Exchange Act is recorded, processed, summarized and reported within the required time periods and is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure due to material weaknesses in internal control over financial reporting.

     

    Changes in Internal Control over Financial Reporting

     

    There were no changes in the Company’s internal control over financial reporting during the three months ended March 31, 2025 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

     

    52

     

     

    PART II - OTHER INFORMATION

     

    ITEM 1. LEGAL PROCEEDINGS

     

    On July 29, 2024, Object3, LLC initiated an arbitration proceeding with the American Arbitration Association, styled Object3, LLC, Claimant, v. Cloudburst Security, LLC, Respondent, Case No. 01-24-0006-9906. The claimant made claims against Cloudburst for unpaid consulting services and associated costs, fees, and interest for the prior 12-month period in the aggregate amount of approximately $228,000. Defendant Cloudburst (a wholly-owned subsidiary) denies that it owes such amount to Claimant. The arbitration is in the early stages, and, as of the date of this quarterly report, we are in negotiations to settle this case.

     

    We know of no other material pending legal proceedings to which we or any of our subsidiaries are a party or to which any of our assets or properties, or the assets or properties of any of our subsidiaries, are subject and, to the best of our knowledge, no adverse legal activity is anticipated or threatened. In addition, we do not know of any such proceedings contemplated by any governmental authorities.

     

    We know of no material proceedings in which any of our directors, officers, or affiliates, or any registered or beneficial stockholder is a party adverse to us or any of our subsidiaries or has a material interest adverse to us or any of our subsidiaries.

     

    ITEM 1A. RISK FACTORS

     

    Our operations and financial results are subject to various risks and uncertainties that could adversely affect our business, financial condition, results of operations, cash flows, and the trading price of our common shares. For risk factors that may cause actual results to differ materially from those anticipated, please refer to “Item 1A. Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2024.

     

    ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

     

    Recent Sales of Unregistered Securities

     

    There were no unregistered sales of equity securities for the three months ended March 31, 2025.

     

    On April 7, 2025, we entered into a pre-funded warrant (“Pre-Funded Warrant”) with Yield Point NY LLC (the “Investor”) for up to 4,500,000 shares of Common Stock issuable to the Investor upon exercise of the Pre-Funded Warrant. We chose to issue the Pre-Funded Warrant in consideration for the Investor’s execution and delivery of the Equity Purchase Agreement, dated April 7, 2025, between us and the Investor in lieu of paying the Investor $1,800,000 in cash.

     

    Use of Proceeds from Registered Securities

     

    Not applicable.

     

    Purchases of Equity Securities by the Issuer and Affiliated Purchasers

     

    None.

     

    ITEM 3. DEFAULTS UPON SENIOR SECURITIES

     

    None.

     

    ITEM 4. MINE SAFETY DISCLOSURES

     

    Not applicable.

     

    ITEM 5. OTHER INFORMATION

     

    None.

     

    53

     

     

    ITEM 6. EXHIBITS

     

    See accompanying Exhibit Index for a list of exhibits filed or furnished with this report.

     

    EXHIBIT INDEX

     

    Exhibit Number   Description
         
    31.1   Certification of Chief Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
         
    31.2   Certification of Chief Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
         
    32.1†   Certifications of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
         
    32.2†   Certifications of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
         
    101.INS   Inline XBRL Document
         
    101.SCH   Inline XBRL Taxonomy Extension Schema
         
    101.CAL   Inline XBRL Taxonomy Extension Schema Calculation Linkbase
         
    101.DEF   Inline XBRL Taxonomy Extension Schema Definition Linkbase
         
    101.LAB   Inline XBRL Taxonomy Extension Schema Label Linkbase
         
    101.PRE   Inline XBRL Taxonomy Extension Schema Presentation Linkbase
         
    104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in exhibit 101)

     

    † This certification is deemed not filed for purposes of Section 18 of the Exchange Act or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended.

     

    54

     

     

    SIGNATURES

     

    Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

      Cycurion, Inc..
      (Registrant)
       
    Date: June 5, 2025 /s/ L. Kevin Kelly
      L. Kevin Kelly
      Chief Executive Officer
      (Principal Executive Officer)
       
    Date: June 5, 2025 /s/ Alvin McCoy III
      Alvin McCoy III
      Chief Financial Officer
      (Principal Financial Officer and Principal Accounting Officer)

     

    55

     

    Get the next $CYCU alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CYCU

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CYCU
    Financials

    Live finance-specific insights

    See more
    • Cycurion Reports Financial Results for the First Quarter 2025

      MCLEAN, Va., June 06, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. (NASDAQ:CYCU) ("Cycurion" or the "Company"), a trusted leader in IT cybersecurity solutions and AI, reports financial results for the first quarter ended March 31, 2025, and provides a corporate update. Financial Highlights Revenues of $3.9 million.Gross Profit of $677,673, up 95.4% year-over-year, with a 17.5% gross margin increase in the first quarter of 2025 compared to $346,714 (8.2% gross margin) in the first quarter of 2024, reflecting a focus on capturing and retaining more profitable business.Adjusted EBITDA of $245,062 (6.3% margin) in the first quarter of 2025 compared to $(68,803) in the first quarter of 2024, r

      6/6/25 8:45:00 AM ET
      $CYCU
      EDP Services
      Technology
    • Cycurion Reports Full Year 2024 Financial Results

      MCLEAN, Va., April 17, 2025 (GLOBE NEWSWIRE) -- Cycurion (NASDAQ:CYCU) ("Cycurion" or the "Company"), a trusted leader in IT cybersecurity solutions and AI, reports financial results for full year ended December 31, 2024, and provides a corporate update highlighting a year of strategic execution, operational discipline, and solid financial performance. Cycurion is poised for a strong 2025, driven by a strategic overhaul focused on sustainable growth and innovation. Over the past year, the company streamlined operations, significantly cutting General and Administrative (G&A) expenses while boosting gross profit for greater financial strength. Cycurion invested heavily in AI-driven te

      4/17/25 8:00:00 AM ET
      $CYCU
      EDP Services
      Technology

    $CYCU
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Cycurion Announces Continued Listing and Trading of its Common Stock and Warrants on NASDAQ

      MCLEAN, Va., June 06, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. (NASDAQ:CYCU) ("Cycurion" or the "Company"), a trusted leader in IT cybersecurity solutions and AI, announces continued listing and trading of its shares of common stock and warrants on NASDAQ. On June 5, 2025, the SEC filed a Form 25 notification of removal from listing and/or registration under Section 12(b) of the Securities Exchange Act of 1934 regarding the Units previously listed and registered by Western Acquisition Ventures Corp, the predecessor company prior to the business combination with Cycurion. Cycurion's shares of common stock and warrants continue to be listed and traded on The Nasdaq Global Market and The Nasd

      6/6/25 2:15:00 PM ET
      $CYCU
      EDP Services
      Technology
    • Cycurion Reports Financial Results for the First Quarter 2025

      MCLEAN, Va., June 06, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. (NASDAQ:CYCU) ("Cycurion" or the "Company"), a trusted leader in IT cybersecurity solutions and AI, reports financial results for the first quarter ended March 31, 2025, and provides a corporate update. Financial Highlights Revenues of $3.9 million.Gross Profit of $677,673, up 95.4% year-over-year, with a 17.5% gross margin increase in the first quarter of 2025 compared to $346,714 (8.2% gross margin) in the first quarter of 2024, reflecting a focus on capturing and retaining more profitable business.Adjusted EBITDA of $245,062 (6.3% margin) in the first quarter of 2025 compared to $(68,803) in the first quarter of 2024, r

      6/6/25 8:45:00 AM ET
      $CYCU
      EDP Services
      Technology
    • Cycurion, Inc. Receives Expected Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q

      MCLEAN, Va., May 29, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. (NASDAQ:CYCU) ("Cycurion" or the "Company"), a trusted leader in IT cybersecurity solutions and AI, today announced that it received an expected deficiency notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC ("Nasdaq") on May 22, 2025 (the "Notice"). The Notice indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Listing Rule") as a result of its failure to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2025 (the "Form 10-Q"), as described more fully in the Company's Form NT 10-Q Notification of Late Filing (the "Form NT 10-Q"

      5/29/25 4:31:36 PM ET
      $CYCU
      EDP Services
      Technology

    $CYCU
    SEC Filings

    See more
    • Cycurion Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - Cycurion, Inc. (0001868419) (Filer)

      6/6/25 5:28:50 PM ET
      $CYCU
      EDP Services
      Technology
    • SEC Form 10-Q filed by Cycurion Inc.

      10-Q - Cycurion, Inc. (0001868419) (Filer)

      6/5/25 9:58:14 PM ET
      $CYCU
      EDP Services
      Technology
    • SEC Form 25-NSE filed by Cycurion Inc.

      25-NSE - Cycurion, Inc. (0001868419) (Subject)

      6/5/25 5:19:50 PM ET
      $CYCU
      EDP Services
      Technology